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GENERAL INTRODUCTION 
2 
OVERVIEW 
This study focuses on the Saccharomyces cerevisiae protein Rho1p. 
Rho1p is of interest because of its membership in the large superfamiiy of 
proteins related to the ras oncoprotein. This discussion wiii describe the iarge 
family of proteins that make up the ras superfamiiy, the structural and 
biochemical characterizations of these proteins, and the physiological function 
of these proteins as they relate to the cell cycle of the organism under study, 
S. cerevisiae. 
The genomes of all eukaryotes examined to date have been shown to 
contain at least one copy of a member of the ras gene family. These genes 
were first Identified as the transforming factors of the Harvey and Kirsten 
strains of rat sarcoma viruses (the name ras was coined as an acronym from 
the words rat sarcoma) (Barbacid, 1987). The Harvey and Kirsten rat sarcoma 
viruses were formed independently after inoculation of helper-independent 
mouse type C leukemia retroviruses into rats (Scolnick et al., 1973). The 
viruses are comprised of sequences derived from the original retrovirus and 
rat genomic sequences. The genomic sequences were transduced because 
of recombinational events occurring between the entering leukemia virus and 
a replication-defective endogenous virus of rats called VL30 (Shih et al., 1978). 
VL30 is present in multiple, heterogeneous copies in rat cell DNA at levels 
between 50 and 100 copies per rat genome. The ras gene was interposed 
within the VL30 sequence (Ellis et al., 1980) and under transcriptional control 
of a promoter in the long terminal repeat sequence of VL30 (Tabin and 
Weinberg, 1985). After the ras gene was transduced by the retrovirus, 
mutational events occurred in its coding region that made the protein 
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hyperactive. Therefore, both the ras oncogene and the VL30 sequences 
contributed to the oncogenic activity of the viruses (Manly et ai., 1988). 
The ras gene was the first oncogene identified in human tumors. When 
DNA purified from the human EJ bladder carcinoma was transfected into 
NIH3T3 cells, focus formation was induced (Watson et al., 1986). It was later 
determined that a mutated cellular ras gene was the cause of the transforming 
properties of the DNA. This demonstration of the oncogenic properties of a 
cellular homolog of a viral ras gene provided unity between spontaneous and 
viral carcinogenesis. Subsequently, the activated ras gene has been identified 
in 40% of human tumors. In fact, ras is the most commonly found oncogene 
in human tumors. 
All p2iras.related proteins characterized to date are guanine nucleotide 
binding proteins (G proteins), possess intrinsic GTP hydrolysis (GTPase) 
activity, and associate with a cellular membrane (Barbacid, 1987). Modified 
p2iras proteins capable of oncogenic transformation have reduced GTPase 
activity, indicating the proteins are active when bound to GTP, and inactive 
when bound to GDP (Barbacid, 1987). p2iras in its active conformation is 
thought to interact with an effector molecule. This interaction may bring about 
the hydrolysis of GTP into GDP, returning the protein to its inactive 
conformation. Proteins capable of increasing the GTP hydrolysis activity of 
p2iras termed GAPs, have been identified (Trahey and McCormick, 1987). 
Alternatively, GAP proteins may function to down regulate p21'^ as activity, and 
not be the actual effector molecule (Hall, 1990). 
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THE R4S GENE SUPERFAMILY 
The ras gene family is part of a larger family of ras-related genes, which 
code for 20-30 kDa G proteins. There are three subfamilies within the ras 
superfamily: they include ras, ypt/rab, and rho. The entire ras superfamily has 
been highly conserved throughout evolution. Within each subfamily there is 
50-90% amino acid identity, whereas between them there is 25-30%. Because 
of this conservation, these genes are likely to have fundamental roles in basic 
cellular functions. The physiological function of most of the proteins belonging 
to the p21 ras-related superfamily is not known. Ras is involved in the 
adenylate cyclase pathway in the yeast S. cerevisiae, but this involvement 
does not occur in mammalian cells. Because of the high degree of amino acid 
similarity in the proteins of the p21'^ ®-related superfamily, however, these 
proteins may not only be structurally but also functionally related. Therefore, 
other members of the p2iras-related superfamily also may be involved in 
neoplastic transformation. 
To date more than fifty p2iras.related proteins have been identified. 
These proteins have been isolated by a number of different approaches. 
These include serendipity, the characterization of yeast mutants, systematic 
purifications of small molecular weight G proteins, and homology searches. 
These isolation methods are now starting to overlap in their isolation of genes; 
therefore, it may be that a majority of the members of the p2iras.related 
superfamily have already been identified (Valencia et al., 1991). 
5 
Ras suMamity 
The ras protein has been localized to the plasma membrane and is l<nown 
to be Involved in growth control. Ras can become oncogenic through both 
qualitative and quantitative mechanisms. Naturally occurring point mutations 
have been identified in the ras coding region at codon positions 12, 13, 59, 
and 61. All of these mutations occur at regions in the protein involved in 
binding with the phosphate group of the guanine nucleotide. These mutations 
cause the ras protein to be hyperactive by decreasing the proteins intrinsic 
GTPase activity. Overexpression of the normal ras gene can also. be 
oncogenic. Both of these phenomena result in a larger proportion of the ras 
protein in a GTP bound state or active conformation, which then leads to a 
larger signal output (Barbacid, 1987). 
S. cerevisiae has two ras genes, RAS1 and A4S2. Disruption of either 
RAS1 or RAS2 shows that neither gene is essential, however, disruption of 
both genes is lethal. RAS2 has been linked to the adenylate cyclase signal 
transduction pathway. S. cerevisiae depends on its intracellular 
concentrations of cAMP to exit from G1 to S phase and to switch from G1 into 
the sporulation pathway (the yeast cell cycle is discussed in detail below). 
Disruption of IRAS2 results in a premature starvation response; one of the 
phenotypes being premature sporulation (Barbacid, 1987). A yeast mutation 
that produces a defective adenylate cyclase, cyr1-1, displays a similar 
phenotype. The phenotype of cells with an activated ras gene is similar to that 
of cells carrying the lAC mutation, which have an elevated adenylate cyclase 
activity and therefore elevated concentrations of cAMP, and bey cells, which 
have a constitutively active cAMP-dependent protein kinase catalytic subunit 
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because they are deficient in the regulatory subunit of the kinase (Toda et al., 
1985). 
It has been determined by In vitro assays using purified ras and adenylate 
cyclase that ras activates adenylate cyclase only when it is bound to GTP 
(Field et al., 1988). Ras proteins control adenylate cyclase activity, but they 
must also have other functions since simultaneous disruption of RAS1 and 
RAS2 is lethal while disruption of adenylate cyclase is not (McCormick, 1989). 
The ras gene family also includes the ral and rap genes. The ra! gene was 
first isolated through a homology search using a probe derived from a 
conserved region found in all ras superfamily proteins but not in any other G 
proteins (Chardin, 1988), whereas the rap gene was isolated through a 
functional assay (Noda et al., 1989). Rap1A was isolated from a cDNA library 
of normal human fibroblasts because of Its ability to revert ras transformed 
cells to a wild type phenotype. (Noda et al., 1989; Kitayama et al., 1989). This 
occurs because raplA interacts with the rasGAP protein, and this is believed 
to prevent ras' interaction with its effector, rasGAP (Freeh et al., 1990). 
Ypt/rab subfamily 
The ypt/rab gene family code for proteins that are involved in the 
secretory process. These proteins have been shown to be involved at specific 
stages of protein transport in participating organelles such as the endoplasmic 
reticulum, the Golgi apparatus, secretory vesicles, and the plasma membrane. 
The mammalian members of this family, rab1-rab4, were isolated through a 
homology search using a probe derived from a conserved region found in all 
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ras superfamily proteins but not in any other G proteins (Touchot et al., 1987). 
YPT1 and SEC4 constitute the yeast homologs. 
The YPT1 gene was the first fas-related gene identified (Gallwitz et al., 
1983). It was fortuitously discovered as an open reading frame between the 
actin and jS-tubulin genes of S. cerevislae having 38% homology to ras. YPT1 
has since been found to be an essential gene (Schmitt et al., 1988) that 
functions early in the secretion process. It codes for a protein that has been 
localized to the Golgi apparatus (Segev et al., 1988). 
Another member of this family, SEC4, was isolated in a screen for 
secretory deficient mutants of yeast cells that had been chemically 
mutagenized (Novick et al., 1980). Twenty-three complementation groups 
resulted from this screen, one of which was SEC4. The temperature sensitive 
mutant of SEC4 was found to be blocked in secretion and to accumulate 
secretory vesicles at its restrictive temperature; therefore, Sec4p is Involved in 
protein transport between secretory vesicles and the plasma membrane 
(Salminen and Novick, 1987). 
Rho sub^ily 
A rho gene was first identified in a cDNA library from the abdominal 
ganglia of the marine snail Aplysia californica (Madaule and Axel, 1985). This 
cDNA was being analyzed for clones homologous to mammalian peptide 
hormones. A clone was isolated that shared weak homology with the a 
subunit of human chorionic gonadotropin. It was noticed that the 
complementary strand encoded an overlapping open reading frame of 192 
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amino acids. Through a computer-assisted search, it was found that the 
deduced protein sequence shared 35% homology with H-ras. 
Segments of the A. californica rho gene were used as probes in 
heterologous hybridization studies to isolate similar sequences from various 
sources (Madaule et al., 1987). Rho homologs were in this way isolated from 
human, rat, yeast, and Drosophita melanogaster DNA. The A. californica 
protein shares 85% homology with the protein isolated from humans. Two 
different clones hybridized to the probe in S. cerevisiae. The sequences of 
these clones were determined, and they were designated RH01 and RH02. 
RH01 is 70% identical to the A. californica rho, whereas RH02 is 57% 
identical. Through studies of cell division cycle (cdc) mutations in yeast, a 
third rAïo-related gene was isolated, CDC42 (Adams et al., 1990). RH01, 
RH02, and CDC42 share 55% amino acid identity in pairwise comparisons. 
rho genes have been highly conserved throughout evolution, as extensive 
regions of the yeast, human, and snail rho proteins share more than 70% 
homology. Three homologs of RH01 have been identified in mammals, rhoA, 
rhoB, and rhoC (Madaule and Axel, 1985; Yeramian et al., 1987; Chardin et al., 
1988), whereas the mammalian protein homologs of CDC42 are termed raci, 
rac2, Gp, and G25K (Didsbury et al., 1989; Polakis et al., 1989; Munemitsu et 
al., 1990). 
RH01 and CDC42 are essential genes in yeast, whereas RH02 is not 
required for cell viability (Madaule et al., 1987; Johnson and Pringle, 1990). 
The lethality of inactivation of RH01 cannot be suppressed by • the 
overproduction of the yeast ras protein or the catalytic subunit of cAMP-
dependent protein kinase. Since a deficiency of ras can be overcome by 
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adenylate cyclase or the kinase, ras and rho must function in independent 
pathways (Madaule et al., 1987). 
rho genes were found to cause cellular transformation, although in the 
system utilized it did not act as strongly as ras. Overexpression of the human 
rhoA gene in Rat-1 and NIH3T3 cells caused the cells to have a reduced 
dependence on serum and to grow to higher cell densities, although it did not 
cause focus formation or growth in soft agar. The cells, however, were 
tumorigenic when inoculated into nude mice (Avraham and Weinberg, 1989). 
Another study demonstrated that the human rhoA gene was capable of 
eliciting neoplastic growth of an established cell line that was stably 
transfected to overexpress rhoA (Avraham, 1990). These cell lines grew to 
high cell densities, grew in soft agar, developed dense foci, and were 
tumorigenic in nude mice. 
Evidence suggests that rho proteins control the process of cellular 
morphogenesis. Rho proteins are specifically ADP-ribosylated by exoenzyme 
C3 from Clostridium botuHnum. This occurs in the putative effector domainat 
asparagine residue 41 (Sekine et al., 1989) and is believed to cause 
inactivation of the protein. ADP-ribosylation of mammalian Rho1p homologs 
by exoenzyme C3 causes disappearance of actin microfilaments and changes 
in cell shape (Chardin et al., 1989). Conversely, microinjection of rhoA protein 
into contact-inhibited mammalian cells rapidly induces intense polymerization 
of actin (Paterson et al., 1990). 
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STRUCTURAL ANALYSIS OF pZl^s-RELATED PROTEINS 
Although within the ras superfamily there is only 25-30% amino acid 
identity, there are discrete regions of these proteins that have higher degrees 
of similarity. These regions include five consensus sequences that are 
conserved in all G proteins, including the protein synthesis factors (EF-Tu, IF-
2, etc.) and the signal transducing G proteins (Gg, Gj, etc.). The guanine 
nucleotide binding domains of the protein synthesis factors and the signal 
transducing G proteins also share 30% similarity with the proteins of the ras 
superfamily. The three dimensional structure of two G proteins has been 
determined — that of EF-Tu and H-ras. It was found that the peptide 
backbones of these two proteins were more than 80% superimposible (Jurnak 
et al., 1990). Therefore, it can be assumed that the structure of all members of 
the ras superfamily will also have a very similar peptide backbone structure 
with that of H-ras. 
The three dimensional structure of H-ras was determined separately in the 
laboratories of Wittinghofer and Kim (De Vos et al., 1988; Brunger et al., 1990; 
Pai et al., 1989; Pal et al., 1990). It consists of a six-stranded /3-sheet whose 
strands are connected by hydrophilic loops and a-helices. The 3-D structure 
places the five conserved regions together on one side of the protein. The 
consensus sequences of the five consen/ed regions are as follows: G-1 
region: Gly-X-X-X-X-Gly-Lys-Ser, G-2 region: Asp-(X)n-Thr, G-3 region: Asp-X-
X-Gly, G-4 region: Asn-Lys-X-Asp, and G-5 region: Ser-Ala-Lys (where X 
represents any amino acid). Regions G-1, G-2, and G-3 interact with the 
phosphate groups of the guanine nucleotide. Region G-2 is also the putative 
effector domain. Regions G-4 and G-5 interact with the guanine base and also 
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stabilize the guanine nucleotide binding pocl<et by interactions with the other 
conserved regions. The naturally occurring point mutations that give ras 
oncogenic properties are in regions G-1 and G-3. Rho1p has one 
nonconserved change In the conserved sequences in the G-4 region. Instead 
of the conserved asparagine residue Rholp has a cysteine residue. This 
difference may account for some functional differences between Rholp and 
other ras-related proteins. 
A conserved region of the ras gene superfamlly is involved with 
localization of the protein. This is the Cys-A-A-X region at the C-terminal end 
of the protein (where A represents aliphatic amino acid, X represents any 
amino acid). The ras protein is processed by removal of its three carboxy 
terminal amino acids, polyisoprenylation of the terminal cysteine residue, 
carboxy-methylation of the new C-terminus, and palmitoylation of any 
upstream cysteine residues. Polyisoprenylation results in a weak association 
with cellular membranes while palmitoylation of the protein results in a strong 
association with the membrane (Hancock et al., 1989). Ras proteins are 
polyisoprenylated by a farnesyltransferase. The C-terminal sequence required 
for this post-translational modification Is Cys-A-A-Ser (Finegold et al., 1991). 
Not all ras-related proteins have upstream cysteine residues, and this lack 
of palmitoylation results in a weaker association with the membrane. Ras-
related proteins lacking upstream cysteines make up for this by having 
positively charged basic residues that can interact with the negatively charged 
lipid head groups of the membrane, which increases their association with the 
membrane (Hancock et al., 1989). 
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Rholp has the Cys-A-A-X sequence, does not have any upstream 
cysteine residues, but does have eight upstream lysine residues. Therefore, it 
most likely utilizes polyisoprenylation and its positively charged residues for its 
association with a membrane. A protein has been found that may be involved 
in the polyisoprenylation of Rholp (Finegold et al., 1991). This is the gene 
product of the CDC43 gene, which is a geranylgeranyltransferase. This 
enzyme has been found to modify the CDC42 gene product in vitro (Finegold 
et al., 1991) and could also modify the RH02ar)d/or BUD1 gene products, 
since each of these proteins contain the consensus sequence used in this 
post-translational modification (Cys-A-A-Leu). 
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THE MOLECULAR SWITCH MECHANISM OF p2iras.RELATED 
PROTEINS 
G proteins are in an inactive conformation when they are bound with GDP 
and an active conformation when they are bound with GTP. The 
conformational shift involves regions G-2, G-3, and the a-helix immediately 
downstream of G-3 (Jurnal< et al., 1990). G proteins function as molecular 
switches by cycling between the inactive, GDP bound conformation and the 
active, GTP bound confomnation. The majority of G protein exists in the cell in 
the inactive conformation. The bound GDP is released at a rate intrinsic to 
each individual G protein. The rate of this release can be Increased by 
interaction with a guanine nucleotide release protein (GNRP). The release of 
GDP leaves the protein in a nucleotide free form. The nucleotide free form 
then binds to GTP since cellular concentrations of GTP are one order of 
magnitude higher than that of GDP (Bourne et al., 1991). The protein is now in 
an active conformation and interacts with its downstream effector. This 
interaction may continue as long as the protein is bound with GTP. The 
protein has an intrinsic GTPase activity which brings the protein back into an 
inactive conformation. The GTPase activity can be accelerated by interaction 
with a GTPase activating protein (GAP). 
There are two points at which outside signals could interact with the 
cycling of G proteins between inactive and active conformations. An outside 
signal could either increase the activity of a GNRP or decrease the activity of a 
GAP, both of which would lead to a higher proportion of the G protein in the 
cell to be In an active conformation. GNRPs and GAPs have been Isolated for 
a number of ras-related proteins. 
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The GNRP for yeast ras is CDC25. The CDC25 gene was first identified as 
a temperature sensitive mutation that caused G1 arrest at the nonpermissive 
temperature. This gene was later cloned, and by genetic analyses it was 
found that the lethality of its disruption was suppressed by a hyperactive ras 
allele but not by overexpression of wild type ras. It was also shown that 
mutationally active alleles of CDC25 had phenotypes similar to those seen in 
strains with genetically activated elements In the ras and adenylate cyclase 
pathway (Broek et al., 1987). Recently, there has been biochemical evidence 
that shows that CDC25 may be the GNRP for ras. By in vitro assays, it was 
shown that CDC25 increases the nucleotide exchange rate of ras (Jones et al., 
1991). 
Takai and colleagues have Isolated a guanine nucleotide dissociation 
inhibitor (GDI) specific for rhoA and rhoB from the rabbit intestine cytosol and 
the bovine brain cytosol (Ohga et al., 1989; Ueda et al., 1990). They found 
that this 27 kDa protein would not interact with other p2iras.related proteins 
such as H-ras, smgp21, or smgp25A. They have isolated another GDI which 
seems to be specific for smgp25A; it does not interact with H-ras, rhoB, or 
smgp21 (Sasaki et al., 1990; Matsul et al., 1990). This 50 kDa protein has 
been cloned, and some sequence homology has been found to CDC25. Two 
proteins that stimulate the dissociation of GDP (GDS) from ras-related proteins 
have been isolated from bovine brain cytosol (Isomura et al., 1990). These 
proteins interact with rhoA and rhoB and are called rho GDS1 and rho GDS2. 
The rho GDSs are inactive towards other members of the ras superfamily such 
as H-ras, smgp21, and smgp25A. 
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The GAP protein was first identified in 1987 by McCormicl< in Xenopus 
laevis as a 120 kDa cytoplasmic factor thiat increased the GTPase activity of 
normal but not activated ras (Trahey and McCormick, 1987). Besides its GAP 
catalytic domain, rasGAP contains two adjacent copies of the noncatalytic src 
homology region 2 (SH2) that is conserved in nonreceptor tyrosine kinases. 
In GAP this SH2 domain mediates interactions with phosphotyrosine ligands 
such as growth factor receptors (EGFR, PDGFR) and cytoplasmic proteins 
(p62) (Moran et al., 1990). The GAP protein is tyrosine phosphorylated in EGF 
and PDGF stimulated cells (Ellis et al., 1990; Molloy et al., 1989). This 
evidence provides the biochemical link between the ras signal transduction 
pathway and the signal transduction pathways induced by several growth 
factors. 
GAP proteins have been purified from many different sources and with 
different ras superfamily specificities. It was first identified in Xenopus laevis 
oocytes in which it activated N-ras (Trahey and McCormick, 1987). The first 
GAP protein isolated was specific for ras and was purified and cloned from 
bovine brain cytosol (Vogel et al., 1988; Gibbs et al., 1988). Two GAPs have 
been purified from bovine brain cytosol that are specific for smgp21 (Kikuchi et 
al., 1989). One article reports the presence of a GAP activity in various 
mammalian cytoplasmic extracts specific for ras and R-ras, and another one 
specific for rhoA (Garrett et al., 1989). Two GAP-like proteins, IRA1 and IFIA2, 
have been cloned in S. cerevlslae that interact with RAS1 and RAS2 (Tanaka et 
al., 1990). 
16 
THE SACCHAROMYCES CEREVISIAE CELL CYCLE 
There are many ras-related yeast proteins that have been found to be 
involved in cellular growth control. These genes include RAS1, RAS2, RH01, 
CDC42, and BUD1. To see how these genes affect growth control, we must 
first look at the normal process of cell division in the organism that is under 
investigation, the yeast S. cerevisiae. 
S. cerevisiae divides by budding, unlike the process of fission that occurs 
in higher eukaryotes (Pringle and Hartwell, 1981). There is a point in G1 called 
"START". After START is completed, the cell is committed to complete the 
next cell cycle. Early in S phase DNA synthesis begins. At about the same 
time, a microfilament ring and a chitin ring form at a location through which the 
bud will emerge. The chitin ring remains with the mother cell as a bud scar. 
While still in early S phase the bud emerges. The distribution of actin changes 
in the cell depending on its stage in the cell cycle. Actin patches are found at 
the locations in which cellular growth is occurring. A cell in S phase has its 
actin concentrated in patches in the bud while actin cables stream back into 
the mother cell and are believed to direct the flow of secretory vesicles to the 
growing bud. In G2 phase nuclear migration takes place and in M phase 
nuclear division occurs. The location of actin now redistributes to patches at 
the junction of the mother and daughter cells because this Is where growth 
must be localized for cytokinesis to occur. The daughter cell is smaller than 
the mother cell when separation occurs; therefore, the daughter cell must 
undergo growth around its entire periphery before it can complete START and 
enter another cell cycle. The distribution of actin patches again changes, now 
to a location around the entire periphery of the cell. 
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Cell-division cycle (cc/c) mutants have been used extensively to study the 
stage-specific events that occur in the yeast cell cycle (Pringle and Hartwell, 
1981). The designation of a CDC gene is made when a particular mutation in 
the CDC gene causes the cells to cease normal development at the same 
point in the cell cycle. Cdc mutations lead to a defect in a particular stage 
specific function of the cell cycle. The immediate effect of this is called the 
primary-defect event and can be caused by the lack of synthesis or function of 
the CDC gene product. Each cdc mutation has a diagnostic landmark that 
may be later than the point at which the protein acts and can be revised as 
new diagnostic landmarks are characterized. 
The yeast cell cycle is a highly ordered series of events. Phenotypic 
analyses of CDC genes Including CDC42 and the phenotyplcally similar genes 
CDC24 and CDC43 indicated the yeast cell cycle is directed by at least two 
parallel, independent pathways (Pringle and Hartwell, 1981). One pathway is 
responsible for DNA replication and nuclear division, whereas an independent 
morphogenetic pathway regulates emergence and development of the bud. 
These two pathways must be coordinated for the cell cycle to proceed 
normally. If there is a lack of coordination, the result can either be prevention 
of bud formation while other cellular processes, including DNA replication, 
continue, such as is the case for CDC24, CDC42, and CDC43. Alternatively, 
excessive bud growth can result in cells budding prematurely or In cells with 
elongated and/or multiple buds. Furthermore, morphological development is 
finely regulated regarding positioning of the bud formation site. Morphological 
mutants in yeast can therefore be divided into three classes, one which 
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involves the inability to localize the position of bud formation correctly, one 
which prevents bud formation, and one which causes excessive bud growth. 
Haploid cells position their buds axially such that mother and daughter 
cells form buds adjacent to their prior mother-daughter junction. Diploid cells 
position their buds bipolarly such that a mother buds either adjacent to the last 
bud or at the pole opposite to the last bud. The daughter cell buds at the pole 
opposite from the previous location of its mother cell (Drubin, 1991). Mutants 
with defects in the positioning of bud sites either bud completely randomly 
{BUD1, BUD2) or bud bipolarly in both diploid and haploid cells {BUD3, BUD4) 
(Chant and Herskowitz, 1991). A fifth bud gene, BUD5, buds randomly but 
also, in combination with another mutant gene, results in the enlarged 
polyploid cell phenotype (Chant et al., 1991). BUD5 also has been found to 
have homology to the GNRP for ras, CDC25 (Powers et al., 1991). 
A group of genes that are known to be involved in the morphogenetic 
pathway of the yeast cell cycle were identified from the characterization of 
mutant alleles that prevent bud formation. Mutations in any of these genes 
cause a similar, uniform phenotype in which buds fail to emerge even though 
membrane expansion and general anabolism continues. These genes Include 
those mentioned previously, CDC24, CDC42, and CDC43, and also an actin 
gene (ACT) (Novick and Botstein, 1985)) and a myosin gene {MY02 
(Johnston et al., 1991)). Other genes affecting bud emergence have been 
identified recently through genetic interactions with CDC24 and/or CDC42 
{BEM1 and BEM2 (Bender and Pringle, 1989; Bender and Pringle, 1991)), by 
isolation of yeast mutants with abnormal budding patterns {BUD5 (Chant et 
al., 1991)), or by overexpression of an actin binding protein (Drubin et al. 
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1988). By themselves bud5 or bem1 mutations do not prevent bud formation, 
however, budS, bem1 double mutants uniformly display the characteristic 
spectrum of bud emergence defects described above. Section I shows that 
RH01 is a member of this group of genes that prevent bud emergence. 
Mutations In another set of genes causes cells to arrest with extremely 
elongated buds. These include CDC3, CDC10, CDC11, and CDC12, which 
code for related proteins of the 10 nm microfilament located at the mother-bud 
neck (Hartwell, 1971; Haarer et al., 1992). Two other cell elongation genes are 
CDC55 and ELM1, which code for a regulatory subunit of a protein 
phosphatase and a protein kinase, respectively (Healy et al., 1991; Myers et 
al., 1992). 
Defects in two other genes are known to cause cell cycle arrest during 
bud development. Depletion of the only protein kinase C homolog yet found 
in yeast, PKC1, results in cells arrested while budded (Levin et al., 1990). 
Growth in reduced calcium concentrations of the calcium requiring allele of 
CDC43, cal1-1, results in a similar phenotype (Ohya et al., 1991; Johnson et 
al., 1990). This obsen/ation further implicated RH01 in the bud development 
process, because as discussed above CDC43 is likely to modify rho proteins 
post-translationally. 
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EXPLANATION OF DISSERTATION FORMAT 
This dissertation has been prepared in accordance with the rules for the 
alternative thesis format as outlined in the Iowa State University Graduate 
College Thesis Manual (1990). This dissertation contains a general 
introduction to the problem addressed with a critical review of the literature. 
The introduction is followed by three research sections, after which there is a 
general summary and conclusions. Finally, the literature cited in the general 
introduction and the general summary and conclusions is given. 
Section I and II are multiple author papers that have been submitted or 
published in the Journal of Cell Biology, respectively. The entirety of Section I 
was done by the doctoral candidate, except for the experiment depicted in 
Figure 6. The paper was written jointly by the doctoral candidate and two 
collaborating principal investigators, Alan Myers and Pascal Madaule. 
Section II was published in the Journal of Cell Biology, Volume 115, 
Number 2, pages 309-319 (October 1991). The work described in Figures 2 
and 6 were done by the author of this thesis. This included construction of the 
GAL'RHOI allele, construction of the yeast strain JJ1, yeast subcellular 
fractionations, production and affinity purification of anti-Rholp antibodies, 
immunoblotting with Rho1p, and immunofluorescence microscopy. The paper 
was written jointly by the doctoral candidate and the other primary 
investigator, Mary McCaffrey, in collaboration with Alan Myers and Pascal 
Madaule. 
The research of Section III was done entirely by the primary author. The 
section was written by the doctoral candidate with editorial contribution from 
Alan Myers. 
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SECTION I: THE YEAST GTP-BINDING PROTEIN Rho1 p IS A 
NEGATIVE REGULATOR OF MORPHOGENETIC 
EVENTS IN CELL DIVISION 
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ABSTRACT 
The Saccharomyces cerevisiae gene RH01 codes for Rho1p, a member 
of the large family of p21^^®-related proteins. Phenotypic analysis showed 
Rho1p functions in regulation of the cell division cycle, as a negative regulator 
of bud formation. Mutational activation of Rho1p or overexpression of RH01 
prevented bud formation and cell division without affecting continuation of 
metabolic activities Including DNA replication and cell growth. Depletion of 
Rho1p caused lethal growth arrest of cells showing a uniform, cell division 
cycle-specific phenotype. Rho1p-depleted cells arrested uniformly with a bud, 
prior to completion of DNA replication. Overall cell growth did not continue, 
however, in contrast to most cell division cycle mutants. The effects of Rho1p 
hyperactivation are similar to those caused by inactivating CDC42, a homolog 
of RH01. Thus, multiple Rho-related proteins function as positive and 
negative regulators of the morphogenetic aspects of cell division. 
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INTRODUCTION 
Rho proteins make up one of tine three known brandies of tine p21'^ ®-
related guanine nucleotide binding protein (Q protein) superfamiiy, which also 
comprises the ypt/rab proteins and the ras subfamily (Madaule and Axel, 
1985; Chardin, 1988; Valencia et al., 1991). Members of this superfamiiy 
contain several evolutionarily conserved amino acids which, based on the 
three dimensional structure of p21 '^'^ ® (Brûnger et al., 1990; De Vos et al., 
1988; Pai et al., 1989; Pai et al., 1990), most likely form a guanine nucleotide 
binding pocket that interacts with GDP and GTP. This structure also is present 
in the trimeric G protein a subunits, which are components of signal 
transduction pathways (Blrnbaumer et al., 1990; Bourne et al., 1990; Gilman, 
1987). The known biochemical functions of G proteins suggest they serve as 
molecular switches in which the GTP bound form represents the activated 
state and the GDP bound form is the resting state. While activated, G proteins 
regulate the function of other molecules with which they Interact. 
Three r/7o-related genes have been described to date in the yeast 
Saccharomyces cerevisiae, namely RH01, RH02, and CDC42, which code for 
proteins approximately 55% identical at the amino acid level in pairwise 
comparisons (Madaule et al., 1987; Johnson and Pringle, 1990). Highly 
conserved counterparts of RH01 and CDC42 have been found in mammals, 
coding for proteins 70-80% identical at the amino acid level to the 
corresponding yeast proteins. The mammalian RH01 homologs are called 
rhoA, rhoB, and rhoC (Madaule and Axel, 1985; Chardin et al., 1988; Yeramian 
et al., 1987), and the CDC42 protein equivalents are termed Gp, G25K, raci 
and rac2 (Didsbury et al., 1989; Polakis et al., 1989; Munemitsu et al., 1990). 
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Individual p21 ""^s-related proteins have been implicated in mediating 
several different cellular processes, p21'^ 2® itself clearly is involved in control of 
cell proliferation (McCormick, 1989). In yeast this function is achieved by 
p2iras stimulation of adenylate cyclase activity, resulting in elevated cAMP 
levels in response to high levels of nutrients in the culture medium (Broek et 
al., 1985). Proteins from the ypt/rab branch such as Sec4p (Salminen and 
Novick, 1987) and Yptip (Baker et al., 1990) mediate different steps in protein 
transport between the endoplasmic reticulum, the Golgi apparatus, and the 
cell surface. Recent evidence suggests that Rho proteins control the process 
of cellular morphogenesis. ADP-ribosylation of mammalian Rholp homologs 
by exoenzyme 03 of Clostridium botulinum causes disappearance of actin 
microfilaments and changes in cell shape (Chardin et al., 1989). Conversely, 
microinjection of RhoA protein into contact-inhibited mammalian cells rapidly 
induces intense polymerization of actin (Paterson et al., 1990). Finally, 
mutations in CDC42 cause specific defects in cellular morphogenesis (Adams 
et al., 1990; Johnson and Pringle, 1990; Ziman et al., 1991). 
In this report the yeast gene RH01 (Madaule et al., 1987) is formally 
defined as a cell division cycle (CDC) gene. Phenotypic analyses of other 
CDC genes including CDC42 and the phenotypically similar gene CDC24 
indicated the yeast cell cycle is coordinated by at least two parallel, 
independent pathways (Pringle and Hartwell, 1981). One pathway is 
responsible for DNA replication and nuclear division, while an independent 
morphogenetic pathway regulates emergence and development of the bud. 
This report indicates RH01 Is involved in control of the morphogenetic cycle. 
Unlike the other CDC genes known to be involved in cellular morphogenesis, 
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however, RH01 functions as a negative regulator of bud formation. Thus, in S. 
cerevlslae different Rho proteins act specifically as positive or negative 
regulators of the morphological changes that occur during the cell cycle. 
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MATERIALS AND METHODS 
Media and genetic manipulations 
Non-selective media for yeast contained 1% Bacto yeast extract (Difco 
Laboratories Inc., Detroit, Ml), 2% Bacto peptone (Difco Laboratories Inc.), 
and 2% carbon source, either glucose (YPD), galactose (YPGal), or raffinose 
(YPR). Selective media contained 0.7% yeast nitrogen base without amino 
acids (Difco Laboratories Inc.), 2% glucose, and auxotrophic requirements 
(uracil, histidine, adenine, leucine, tryptophan) at 20 iwg/ml as required. 
Selective media for transformation also contained 1.2 M sorbitol. Solid media 
contained 2% agar. Sporulation medium (KAc) contained 0.1% glucose and 
1% potassium acetate. Dissection of tetrads was performed by standard 
methods (Rose et al. ,  1990). Yeast strains were transformed with 1-5 ixq 
purified linear or circular plasmid DNA as described (Rose et al., 1990). 
Aiieie, plasmid, and strain œnsùruction 
Plasmids and strains used in this study are described in Tables 1 and 2, 
respectively. DNA manipulations were perfomed according to standard 
procedures (Ausubel et al., 1989; Sambrook et al., 1989). Construction of the 
RH01 null allele rho1::HIS3 and the point mutant were described by 
Madaule et al. (1987). Construction of the conditional allele GAL-RH01 was 
described by McCaffrey et al. (1991). In this construct the GAL10 promoter 
region extending to eight nucleotides upstream of the GAL10 Initiation codon 
is fused to RH01 beginning seven nucleotides upstream of its initiation codon. 
Strain MM50 was constructed by transforming the RI-i01/rho1::HIS3 
heterozygous diploid W303ARH01 (Madaule et al., 1987) with plasmid 
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pMM105. Transformants were induced to sporulate on KAc medium, meiotic 
products were separated on YPGal plates by micromanipulation, and spore 
colonies prototrophic for both histidine {rho1::HIS3) and uracil (pMM105) were 
identified. Mating tests verified MM50 was haploid. Strain JJ1 was 
constructed by transformation of wild type strain W303-1A with plasmid 
pMM107 linearized at the unique Nco\ site in URA3. 
Strain 5c was derived from a cross between MM50 and the act1-2 strain 
NY273, both of which had been maintained on stock plates for several 
months. Southern hybridization analysis of 25 spore clones revealed the 
presence of two distinct RH01 alleles, the wild type allele from NY273 and 
rho1::HIS3 from MM50, in approximately 50% of the meiotic products (data 
not shown). Furthermore, auxotrophic markers heterozygous in the mating 
product were recovered in 25% of the viable spore colonies, not the expected 
value of 50%. These results indicated the mating product was tetraploid. One 
spore clone from this cross, 5c, was shown by Southern blot analysis to be 
homozygous for rho1::HIS3 and to contain plasmid pMM105. Strain 5c 
sporulated efficiently and thus was heterozygous at the MAT locus. The trp1, 
Ieu2, acle2, and act1-2 markers all segregated 1:1 in tetrads derived from 5c, 
indicating the strain was also heterozygous at each of these loci. 
Fluorescence microscopy 
For visualization of actin and tubulin cells were grown to early log phase 
and fixed by addition of formaldehyde (3.7% final concentration) directly to the 
culture. Cells were then treated for fluorescence microscopy, including 
glusulase digestion to remove cell walls, as described (Adams and Pringle, 
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1984). Minor modifications of this procedure were described by Pringie et al. 
(1990). Actin was visualized using rhodamine-labeled phalloidin (Molecular 
Probes Inc., Eugene, OR) as described by the manufacturer, or using 
monoclonal antibody as the primary stain and rhodamine-labeled secondary 
antibody (Amersham Corp., Arlington Hts., IL). Tubulin was visualized using 
primary rabbit antibody (Accurate Chemical & Scientific Co., Westbury, NY) 
and fluorescein isothiocyanate labeled goat anti-rabbit secondary antibodies 
(Sigma Chemical Co., St. Louis, MO). Cell wall chitin was visualized by 
staining with Cellufluor (Polysciences Inc., Warrington, PA) and nuclei were 
visualized using 4',6-diamidino-2-phenylindole (DAPI; Sigma Chemical 
Company, St. Louis, MO) as described (Pringie et al., 1990). 
Quantitab'on of DNA content per cell and dry weight per cell 
Cells were harvested from cultures, fixed, treated with RNAase A, and 
stained with propidium iodide as described (Nash et al., 1988). The stained 
cells were filtered through a 36 /nm mesh and analyzed for fluorescence using 
the EPICS Profile 1 or EPICS V Flow Cytometer from Coulter. Dry weight 
measurements were performed according to Pringie and Mor (1975). 
GTP tending assays 
Guanine nucleotide binding activity was measured by a rapid filtration 
technique (Anderson and Lacal, 1987). The total soluble cell fraction (S3) was 
prepared as described by McCaffrey et al. (1991). These extracts (75 fig total 
protein) were incubated in 0.4 ml nucleotide binding buffer containing 20 mM 
Tris-HCI, pH 8.0, 0.5 mM MgCl2, 0.1 mg/ml bovine serum albumin, 1.0 mM 
dithiothreitol, 1.0 ^ M [^H]GDP (10.8 Ci/mmole) (NEN Research Product, 
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Boston, MA), for 90 min at 37°C. The binding reaction was stopped by 
addition of 1.0 ml ice cold nucleotide binding buffer lacking GDP, and protein 
was collected by filtration through BA85 nitrocellulose filters. The filters were 
washed twice with 5 ml binding buffer and dried, after which bound GDP was 
quantified by scintillation counting. 
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RESULTS 
Ph&notype œused by overexpression ofRHOI 
The effects oWHOI overexpression were examined in strain JJ1, in which 
the hybrid gene GAL-RH01 is integrated into the chromosomal URA3 locus as 
part of a multiple copy tandem repeat (Figure 1, Lane 2). JJ1 also contains a 
wild type RH01 gene. Thus, in galactose medium RH01 was expected to be 
expressed at very high levels owing to induction of the GAL10 promoter, 
whereas in glucose medium JJ1 was expected to express RH01 at wild type 
levels. Indeed, previous quantitative analysis of expression from the two 
copies of GAL-RH01 present in another strain, MM50, showed Rho1p was 
present at approximately 20-fold higher levels than wild type cells during 
growth in galactose (McCaffrey et al., 1991). immunoblot analysis of strain 
JJ1 indicated an even larger increase in Rholp level upon induction of GAL-
RH01 (McCaffrey et al., 1991), and a soluble extract from galactose-induced 
JJ1 cells contained 40-fold greater GDP binding activity than extracts from 
glucose-grown JJ1 cells (data not shown). 
JJ1 cells were grown in glucose medium (YPD) to early log phase, then 
harvested by centrifugation and resuspended at low cell density in galactose 
medium (YPGal). Cells continued to divide for about eight hours after 
induction of GAL-RH01, at which point growth of the cultures ceased. This lag 
period most likely was the time necessary for Rholp concentration to reach a 
toxic level. After 48 hours In YPGal only 5% of the cells formed a colony when 
plated on YPD. This defect is specific to induction of GAL-RH01, because JJ1 
grown in glucose had a colony forming efficiency of approximately 90% from 
either log phase cultures or stationary phase cultures up to one week old. 
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Figure 2A shows the morphology of JJ1 cells during induction of GAL-
RH01. The cells display normal morphology for at least eight hours in YPGal. 
Twenty-four hours after induction of GAL-RH01, the cells were unbudded, 
extremely enlarged, and often contained a vacuole filling nearly their entire 
volume. This morphology did not evolve further over 48 hours in YPGal. 
Quantitative measurements showed the dry weight of JJ1 cells increased 
approximately three-fold during induction of GAL-RH01 (data not shown). 
This terminal phenotype was obsen/ed regardless of the cell density at the 
time of growth arrest. 
Additional morphological analyses of JJ1 cells are shown in Figures 2B 
and 2C. The actin cytoskeleton of JJ1 cells was visualized during a time 
course induction of GAL-RH01 by staining with rhodamine-phalloidin (Figure 
28). For at least four hours after exposure to galactose, JJ1 cells displayed 
the assymetric actin distribution pattern typical of wild type cells, with 
concentration of actin patches in the bud and actin cables extending from the 
bud into the mother cell. After 24 hours in galactose medium, however, the 
organization of actin had changed to a distribution of patches throughout the 
enlarged cells. This pattern of actin staining is similar to that in cells bearing 
the conditional-lethal mutation act1-1 at the restrictive temperature (Novick 
and Botstein, 1985). Assembly of the bud emergence site also was defective 
in JJ1 cells after induction of GAL-RH01, as shown by staining of chitin with 
the fluorescent dye Cellufluor (Figure 2C). Prior to induction of GAL-RH01 JJ1 
cells display localized depostion of chitin at the bud neck, typical of wild type 
cells. After 24 hours in galactose medium, however, chitin is located over the 
entire periphery of the cell. Finally, immunfluorescence staining of tubulin 
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showed that most of the enlarged cells had formed mitotic spindles but that 
these elongated only rarely (data not shown). 
Figure 3A shows the DNA content of JJ1 cells quantified during a time 
course of GAL-RH01 induction. Exponentially growing JJ1 cells, during the 
first three hours of induction in YPGal, contained approximately equal 
numbers of cells in the G1 (1N DNA content) or G2 (2N DNA content) phases 
of the cell cycle. After six hours of induction JJ1 cells appeared to have an 
elongated G2 phase, because approximately 75% of the cells displayed 2N 
DNA content. After nine hours of induction virtually the entire cell population 
contained 2N DNA. At this time cell division had ceased and the great majority 
of cells were unbudded, but still of normal size (Figure 2A). DNA continued to 
replicate in the absence of cell division, increasing to 4N in the enlarged cells 
found 24 hours after induction of GAL-RHOI. Nuclear staining with DAPI 
showed the majority of 4N cells to be uninucleate, however, approximately 5% 
of the observed cells showed two distinct nuclei (data not shown). 
Phenotype of cells bearing the activating muta^on 
The effects of overproducing Rho1p were compared to those caused by a 
point mutation, intended to activate the protein by impairing its 
ability to hydrolyze GTP (Madaule et al., 1987). Two congenic yeast strains 
were constructed which contain, in addition to the native RH01 locus, an extra 
RH01 allele integrated into the chromosomal URA3 locus. Control strain 
MM11 contains a second wild type RH01 gene, whereas the extra RH01 allele 
in strain MM10 \s rho1^^^^^. Figure 4 shows the growth characteristics and 
cell viability of MM10 and MM11 during growth in rich glucose medium (YPD). 
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The doubling time of the mutant is approximately three hours, 
whereas that of the control strain is approximately 1.5 hours. Saturated 
cultures of the rhol^ '^ ^^ mutant contained approximately 1.3 x 10® cells/ml, 
whereas in the same medium the control strain continued cell division until 
reaching approximately 2.3 x 10® cells/ml. Thus, the mutant strain seems to 
cease cell division during late log phase. The mutant cells displayed 
normal colony forming efficiency while cultures were in early log phase growth, 
however, they lost viability rapidly when cultures reached saturation, exhibiting 
20% colony forming efficiency 15 hours after growth arrest and less than 10% 
colony forming efficiency after two days In culture. Surviving colonies from 
saturated r/7o7^^®®® cultures, when inoculated into fresh YPD medium, 
exhibited the same growth and sun/ival properties as the original culture. 
Thus, the surviving colonies were not revertants failing to express the 
rho1 '^^ ^^ phenotype. 
Figure 5 shows the morphology of cells. In saturated cultures 
these cells were enlarged somewhat compared to the control strain. 
Furthermore, chitin deposition was delocalized on the surface of rho1 '^^ ^^ 
cells, whereas chitin was localized at bud scars in the control strain. Thus, the 
cell enlargement and delocalized chitin deposition defects described above for 
the GAL-RHOI strain JJ1 were also exhibited by the strain MM10. 
The morphological effects of were more severe in saturated cultures 
than in early log phase cells, however, abnormal chitin deposition also was 
observed during log phase growth. 
The actin cytbskeleton of a mutant was characterized in log 
phase cells. The multicopy plasmid pMUT bearing was introduced 
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into wild type strain NY13. Transformants were grown to mid-log phase in 
YPD medium and stained with antibodies to visualize actln. As shown In 
Figure 6, the transformants displayed gross abnormalities in actln structure 
compared to wild type strains. In particular, about 20% of the cells contained 
a large bar of polymerized actin in the cell Interior, This structure closely 
resembles the abnormal actin structures observed In cells bearing the 
conditional-lethal mutation act1-2 grown at the permissive temperature 
(Novick and Botstein, 1985), in cells overexpressing an 85 kDa actin binding 
protein (Drubin et al., 1988), or in cells deficient in profilin (Haarer et al., 1990) 
or tropomyosin (Liu and Bretscher, 1989). 
The effects of are dominant over wild type RH01, because one 
copy of each allele is present in strain M M10. Furthermore, because the total 
number of RH01 genes Is the same In MM 10 and wild type control strain 
MM11, the observed phenotypic effects of are due specifically to the 
point mutation, not the level of Rholp expression. 
Spontaneous diploidization ofGAL-RHOI orrhol^ ^^^ cells 
The data presented above Indicate activation of Rholp function, either by 
increasing expression of the wild type protein or by the rho1 '^^ ^^ mutation, 
blocks bud formation but does not prevent continuation of other cell cycle 
events including cell growth and DNA replication. Further evidence that 
increased Rholp activity prevents cell division in conditions of continued DNA 
synthesis comes from the observation that galactose grown, haploid cells 
containing GAL-RH01 at low copy number (MM50), or cells bearing rho1 '^^ ^^ 
(MM10), spontaneously produced diploid derivatives during standard culture 
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maintenance and storage at 4°C for extended periods of time. Tlie same 
phenomenon was also observed with cells bearing the act1-2 mutation. This 
conclusion is based on the observation that meiotic spore clones derived from 
a cross between presumably haploid act1-2 and GAL-RH01 strains were still 
heterozygous at several genetic and molecular markers. Some of these 
meiotic clones sporulated, indicating heterozygosity at the MAT locus. 
Quantitation of DNA content by flow cytometery also showed the 
strain MM 10, originally constructed in a haploid background, converted 
spontaneously to a diploid after maintenance on stock plates for several 
months (data not shown). 
Phenotype caused ty Rholp depletim 
In haploid strain MM50 the endogenous RH01 gene has been replaced 
by the non-functional, disrupted allele rho1::HIS3. Rholp is present, however, 
expressed from GAL-RH01 present on the low copy number plasmid pMM105 
(Figure 1, Lane 4). As expected, MM50 cells are dependent on the presence 
of galactose for viability, and are depleted of Rholp when grown in glucose 
medium (McCaffrey et al., 1991). A related strain dependent on galactose for 
Rholp production is 5c, a diploid homozygous for rho1::HIS3 that contains 
one copy of the GAL-RH01 plasmid pMMIOS per haploid genome (Figure 1, 
Lane 5). 
MM50 or 5c cells were precultured in rich galactose medium (YPGal), then 
harvested by centrifugation and resuspended in rich glucose medium (YPD). 
Cells divided four to six times over a period of approximately nine hours, after 
which time cell division ceased suddenly. This delay is likely to be the time 
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required for dilution of Rho1p below a critical level, because MM50 or 5c cells 
grown in galactose medium contain approximately a 20-fold excess of Rho1p 
compared to wild type cells (McCaffrey et a!., 1991). Rho1p-depleted cells 
were inviable, as shown by their colony forming efficiency of less than 1% on 
galactose medium. Figure 7 shows the great majority of cells arrested in the 
budded phase of the cell cycle, with buds frequently elongated compared to 
wild type cells (Panels A, C, E). Another unusual feature was an enlarged and 
highly refringent vacuole pinched by the bud neck (data not shown). This 
morphology did not change appreciably over 24 hours in glucose medium, 
except that the vacuole was no longer obvious. In particular, Rholp depleted 
cells never enlarged. 
Fluorescence staining of DNA, shortly after the time of arrest, showed the 
nucleus usually migrated toward the bud neck and frequently elongated from 
the mother cell towards the bud (Figure 7, Panels A, B). In no case, however, 
had the nucleus divided. Immunofluorescence staining of tubulin in the 
arrested cells revealed a short spindle in the bud neck region (data not 
shown). The actin cytoskeleton in Rholp-depleted cells displayed typical 
patches concentrated in the bud, however, actin cables extending into the 
mother cell could not be visualized (Figure 7, Panels C, D). The Rholp-
depleted cells were able to concentrate chitin at the bud neck (Figure 7, 
Panels E, F). 
Figure SB shows the DNA content of MM50 and 5c cells quantified over a 
Rholp depletion time course. The proportion of cells in G1, S, and G2 phases 
does not change during the first six hours of incubation in glucose medium. 
After nine hours in glucose medium, the time at which cells arrest and lose 
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viabllty, the DNA content of the great majority of cells was Intermediate 
between the G1 and G2 levels, seemingly in S phase. This effect is particularly 
clear in the diploid strain 5c, which allows good resolution of cells in G1, S, or 
G2 phase. 
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DISCUSSION 
The data presented here place RH01 in a group of yeast genes that 
function in the process of bud formation, including ACT1 (Novick and Botstein, 
1985), MY02 (Johnston et al., 1991), CDC24 (Bloat et al., 1981), CDC42 
(Adams et al., 1990; Johnson and Pringle, 1990), and CDC43 (Adams et al., 
1990). Mutations in any of these genes cause a similar, uniform phenotype in 
which buds fail to emerge even though membrane expansion and general 
anabolism continues. As a result cells become greatly enlarged and increase 
in dry mass. Secretion is delocalized, as shown by chitin deposition around 
the entire cell surface rather than at the site of bud formation, and the actin 
cytoskeleton displays characteristic abnormalities. In addition, the mutants 
continue multiple rounds of DNA synthesis in the absence of budding, causing 
polyploidy and, in some instances, a significant proportion of cells to become 
multinucleate (Adams et al., 1990). Additional genes affecting bud emergence 
have been identified through genetic interactions with CDC24 and/or CDC42 
(Bender and Pringle, 1989; Bender and Pringle, 1991) or by isolation of yeast 
mutants with abnormal budding patterns (Chant and Herskowitz, 1991; Chant 
et al., 1991) (see Drubin, 1991 for review). In some instances mutations in 
these genes affect bud site localization and/or prevent bud formation in a 
minority of cells in the population. For example, neither àucfS nor bem1 
mutations by themselves prevent bud formation, however, bud5, bem1 double 
mutants uniformly display the characteristic spectrum of bud emergence 
defects described above (Chant et al., 1991). 
RH01 is unique among genes known to be Involved in morphological 
development in that gene activation uniformly caused the characteristic 
40 
phenotype arising from bud emergence defects. JJ1 cells clearly display the 
entire spectrum of bud emergence defects when Rho1p levels are increased 
by induction of GAL-RH01, but is completely normal when expression from 
the GAL10 promoter is repressed. The presumed activating mutation 
also caused the cell enlargement and chitin delocallzation defects, 
although only when cultures reached relatively high cell density. Continuation 
of DNA synthesis In the absence of cell division also was indicated in 
strains from the fact that MM10 spontaneously converted to a diploid, Thus, 
RH01 functions to block bud emergence. In contrast, bud emergence defects 
are caused by conditional mutations in ACT1, MY02, CDC24, CDC42, and 
CDC43, which presumably inactivate the corresponding gene products. 
These genes, therefore, code for positively acting factors required for bud 
emergence to occur. 
The phenotypic similarities between mutations activating RH01 or 
inactivating CDC42 suggest Rho1p and Cdc42p, G proteins 52% identical to 
each other, regulate the same step in cellular morphogenesis. The effector 
region of the two proteins, predicted to interact with a downstream protein in a 
signaling pathway, is identical over nine residues with the exception of one 
highly conservative substitution. Therefore, Rho1p and Cdc42p may interact 
with the same effector molecule, one with an inhibitory effect and the other 
with a stimulatory effect. Competitive interactions between two p21''®®-related 
G proteins with the same effector molecule has been proposed to explain the 
ability of the mammalian rap1A gene (also called K-rev or smgp21) to reverse 
the transformed phenotype Induced by H-ras (Pizon et al., 1988; Kitayama et 
al., 1989; Zhang et al., 1990). In addition to the effector region, Rholp and 
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Cdc42p are also highly homologous at the C terminal C-A-A-X box known to 
be a signal for post-translational modification by prenylation. Thus, the two 
homologous proteins might also both interact with the CDC43 product, 
thought to be a geranylgeranyltransferase that post-translationally modifies the 
C-terminus of the CDC42 gene product (Finegold et al., 1991). 
Removal of Rholp's negative effect on bud formation caused a lethal 
defect while bud development was In progress. Considering the extensive 
series of events required for establishment of cell polarity, bud emergence, 
and bud growth, specific biochemical mechanisms are likely to regulate the 
ordering of steps in the morphogenetic pathway. The data presented above 
suggest Rholp functions as a regulatory G protein to block a step in this 
pathway, such that its hyperactivation prevents bud emergence. Conversely, 
removal of Rholp may allow execution of this specific step earlier than normal 
In the cell cycle, allowing premature bud formation. Discoordination of 
morphogenesis with other cell cycle events, for example the obsen/ed nuclear 
migration prior to completion of S phase, could be responsible for the 
observed lethal phenotype. A role of Rholp in ordering specific steps in the 
yeast morphogenetic pathway would be consistent with results linking rhoA, 
rhoB, and/or rhoC function to formation of actin filaments in mammalian cells 
(Chardin et al., 1989; Paterson et al., 1990), because cytoskeletal organization 
certainly is a critical step In cellular morphogenesis. The primary effect of 
Rholp activity is not known, however, recent data indicating Rholp is located 
in the Golgi apparatus and post-Golgi vesicles (McCaffrey et al., 1991) suggest 
vesicle delivery or fusion during bud initiation and/or growth as possible 
targets of Rholp regulation. 
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The terminal arrest morphology of Rho1p-depleted cells is distinct in that 
cells cease division in the budded phase of the cell cycle, but do not continue 
overall cell growth. Similar terminal arrest phenotypes were observed 
previously in two instances. The calcium requiring mutation cal1-1, an allele of 
CDC43 (Ohya et al., 1991; Johnson et al., 1990), causes lethal growth arrest 
with this distinctive budded morphology when cells were grown in media with 
reduced calcium concentration (Ohya et al., 1984). As mentioned above, a 
presumed lack of function mutation In CDC43/CAL1 prevented bud 
emergence (Adams et al., 1990). Thus, these two distinct phenotypes, 
caused specifically by depletion or activation of Rholp, respectively, were also 
caused specifically by different alleles of CDC43/CAL1. The second Instance 
where the Rholp depletion phenotype was obsen/ed previously involved the 
yeast gene PKC1, which codes for a protein approximately 50% identical over 
the catalytic domain to protein kinase C isozymes of the rat (Levin et al., 1990). 
This terminal phenotype was observed upon depletion of the PKC1 product 
from yeast cells using the same GAL promoter strategy described above for 
RH01 (Levin et al., 1990). The fact that depletion of Rholp or the PKC1 gene 
product seemingly has the same effect on the cell cycle suggests the two 
proteins may be part of a single regulatory pathway. 
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TABLES 
Table I. List of plasmids 
Plasmid Vector 
Replication 
Origin 
Prototrophic 
Marker Insert 
pwr YEp352Ai 2fi circle URA3 RH01 
pMUT YEp352A 2fi circle URA3 
pMM105 pBM1502 CEN-ARS URA3 GAL-RH01 
PMIVI107 Ylp3523 None URA3 GAL-RHOi 
"• YEp352A is identical to plasmid YEp352 (Hill et al., 1986) except for the 
Inclusion of a Ps/I site within the URA3 gene. 
2 (Johnston and Davis, 1984) 
3 (Hill et al., 1986) 
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Table II. List of strains 
Strain Genotype Source 
W303-1A^ MATa, trp1, ade2, his3, Ieu2, ura3, cani, R. Rothstein^ 
RH01 
MMlb MATa, trp1, acle2, his3, Ieu2, ura3-rho1^^^^^- This study 
URA3, RH01 
IVIIVI11 MATa, trp1, acle2, his3, Ieu2, cani, ura3-
RH01'URA3, RH01 
This study 
MIVI50 MATa, trp1, ade2, hls3, Ieu2, can1, uraS, This study 
rho1::HIS3, [plasmid pMM105] 
W303-1A was the wild type parent used to construct all mutant strains. 
The specific auxotrophic markers are trp1-1, ade2-1, his3-11,15, Ieu2-
3,112, and ura3-1. 
2 Department of Human Genetics and Development, College of 
Physicians and Surgeons, Columbia University, New York, NY 
® Department of Cell Biology, Yale University School of Medicine, New 
Haven, CT 
 ^GAL'RHOI is integrated as a multiple copy, tandem repeat. 
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Table II. List of strains (continued) 
Strain Genotype Source 
NY13 MATa, ura3 P. Novick^ 
NY273 MATa, uraS, act1'2 P. Novick 
5c MATa/MATot, rho1::HIS3/rho 1::HIS3, This study 
ADE2/ade2, TRP1/trp1, LEU2/leu2, 
ACT1/act1-2, [plasmid pMM105] 
W303ARH01 E î i î 1
 
1
 
Madaule etal., 
ade2/ade2, his3/hls3, Ieu2/leu2, ura3/ura3 1987 
JJ1 MATa, trp1, ade2, his3, Ieu2, can1, ura3, This study 
GAL-RH01 (URA3)^ 
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Figure 1. Copy number of RH01 genes. Total yeast DNA was digested with 
EcoRl, separated by agarose gel electrophoresis, transferred to nitrocellulose 
filters, and probed with the 1.6 kb EcoRI fragment containing RH01 (Madaule 
et al., 1987). Lanes: 1, W303-1A; 2, JJ1; 3, W303-1A; 4, MM50; 5, 5c. The 
fragment of apparent molecular mass 1.6 kb contains wild type RH01 
(Madaule et al., 1987), that of 2.6 kb contains rho1::HIS3 (Madaule et al., 
1987), and that of 1.3 kb is derived from GAL-RH01. 
Figure 2. Morphological abnormalities caused by overexpression of 
RH01. (A) Nomarski optics. Strains JJ1 or W303-1A (marked "aW303") 
were grown to mid-log phase (3.0 to 5.0 x 10^ cells/ml) in liquid YPD 
medium, harvested by centrifugation, washed once in YPGal, resuspehded 
at the original cell concentration, and returned to an incubator-shaker at 
30°C (0 hours). At the indicated times thereafter samples of the culture 
were removed, sonicated briefly, and photographed under Nomarski 
optics. All images are of the same magnification. (B) Actin stain. Cells 
were grown as described in panel A. Nomarsky optics is shown in the top 
set of panels. Staining of actin with rhodamine-phalloidin showed normal 
actin localization in budded cells four hours after inoculation in YPQal and 
persistent actin patches throughout the enlarged cells after 24 or 48 hours 
in YPGal. (C) Double stain for chitin and DNA. Cells were grown as 
descnbed in panel A. Staining with Cellùfluor showed distinct localization 
of chitin at the bud neck in JJ1 cells exposed to galactose for four hours, 
and delocalized chitin deposition over the entire cell periphery in cells 
exposed to galactose for 24 hours. The nucleus was also visible in the four 
hour sample owing to staining with DAPI, but was obscured in the 24 hour 
sample by the bright chitin stain. All images are of the same magnification. 
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Figure 3. Flow cytometric analysis of DNA content. (A) GAL-RHOI was 
induced in JJ1 as described in Figure 2. At the indicated times after 
switching ceils to YPGal medium samples were removed from the culture 
and stained with propidium iodide. Fluorescence per cell was then 
quantitated by flow cytometry. As a control JJ1 cells also were transferred 
from the YPD preculture to YPR medium containing raffinose, a sugar that 
strongly represses the GAL10 promoter. The peaks designated as 1N and 
2N DNA contents in the YPGal culture correspond precisely to the same 
range of fluorescence intensities as the 1N and 2N peaks indicated for the 
YPR culture. (B) The galactose-dependent strains MM50 and 5c were 
precultured in YPGal medium to early log phase (approximately 0.5 x 10^ 
cells/ml), harvested by centrifugation, washed once in YPD medium, and 
resuspended at the original cell density in YPD. Samples were removed at 
the indicated times after switching cells to YPD and analyzed for DNA 
content by flow cytometry. The positions of peaks designated as 1N, 2N, 
and 4N correspond to the range of fluorescence intensities observed in 
control haploid and diploid strains (data not shown). 
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Figure 4. reduces growtli rate and causes letliality in stationary 
phase. Strains MM10 and MM11 (wild type) were inoculated from 
fresh YPD plates into liquid YPD medium at very low cell density, and grown at 
30°C. Analysis began when the cell density reached approximately 5 x 10^ 
cells/ml (0 hours). At each time point, samples of the cultures were sonicated 
briefly and cell density was determined by counting in a hemacytometer. Cells 
were diluted in sterile water to 1000 cells/ml, and 200 cells were plated for 
single colonies on fresh YPD plates. Colony forming efficiency was measured 
by counting the colonies visible after growth for three days at 30°C. 
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Figure 5. Cell size and chitin deposition are abnormal in strains. 
Strains MM10 and MM11 were inoculated from YPD pregrowth cultures into 
fresh YPD medium at approximately 1.0 x 10^ cells/ml. Samples were taken 
after four hours (marked "Log phase") or after twenty-four hours (marked 
"Stationary phase") and stained with the chitin-specific dye Cellufluor. 
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NY13+ NY273 
pMUT {act1-2) 
Figure 6. causes abnormalities in the actin cytoskeleton. Plasmid 
pMUT, comprising in the 2/t m circle-based plasmid YEp352A, was 
transformed into wild type strain NY13. Transformants grown to log phase 
were stained for actin using monoclonal anti-actin antibody and rhodamine-
labeled secondary antibody. Approximately 20% of the cells displayed an 
actin "bar" similar to that depicted in the figure. The act1-2 strain NY273 grown 
at 23°C and stained by the same procedure is shown for comparison. The 
wild type actin staining pattern was shown in Fig. 2B. 
Figure 7. Morphology of cells depleted of Rho1 p. MM50 and 5c cells were 
precultured in YPGal medium, then switched to YPD as described in Figure 
3B. Cells were analyzed after 14 hours in YPD at which time colony 
forming efficiency on YPGal plates had dropped to below 1%. (A) 5c 
visualized under Nomarski optics. (8) Nuclei in 5c stained with DAPI. This 
is the same field shown in Panel A. (C) 5c visualized under Nomarski 
optics. (D) Actin in 5c stained with rhodamine-phalloidin. This is the same 
field shown in Panel C. (E) MM50 visualized under Nomarski optics. (F) 
Cell wall chitin in MM50 stained with Cellufluor. This is the same field 
shown in Panel E. 
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SECTION II: THE SMALL GTP-BINDING PROTEIN Rho1 p IS 
LOCALIZED ON THE GOLGI APPARATUS AND POST-
GOLGI VESICLES IN SACCHAROMYCES CEREVISIAE 
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The Small GTP-binding Protein Rholp is Localized on the 
Golgi Apparatus and Post-Golgi Vesicles 
in Saccharomyces cerevisiae 
Mary McCaffrey, Joni S. Johnson*, Bruno Goud^, Alan M. Myers*, Jean 
Rossier, Michel R. Popoff+, Pascal Madaule, and Patrice Boquet + 
Laboratoire de Physiologie Nerveuse, CNRS, Gif-sur-Yvette, 91198 
Cedex, France; *Departnnent of Biochemistry and Biophysics, Iowa State 
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ABSTRACT 
In Saccharomyces cerevisiae the p21''as-relatecl protein Rho1p is 
essentially the only target for ADP-ribosylatlon by exoenzyme C3 of 
Clostridium botulinum. Using C3 to detect Rho1p in subcellular fractions, 
Rho1p was found primarily in the 10,000 x g pellet (P2) containing large 
organelles: small amounts also were detected in the 100,000 x g pellet (PS) 
and cytosol. When P2 organelles were separated in sucrose density 
gradients, Rho1p comigrated with Kex2 activity, a late Golgi marker. Rho1p 
distribution was shifted from P2 to PS in several mutants that accumulate post-
Golgi vesicles. Rholp comigrated with post-Golgi transport vesicles during 
fractionation of P3 organelles from wild type or sec6 cells. Vesicles containing 
Rholp were of the same size but of different density than those bearing 
Sec4p, a p2iras.related protein located both on post-Golgi vesicles and the 
plasma membrane. Immunofluorescence microscopy detected Rholp as a 
punctate pattern, with signal concentrated towards the cell periphery and in 
the bud. Thus, in S. cerevisiae Rholp resides primarily in the Golgi apparatus 
and also in vesicles that are likely to be early post-Golgi vesicles. 
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INTRODUCTION 
G proteins are regulatory proteins that bind GTP and exhibit slow GTP 
hydrolysis activity. The two structural states of G proteins, GTP bound or GDP 
bound, are finely regulated in response to specific signals. GTP binding 
results in structural changes that lead to transmission of a signal, while GTP 
hydrolysis returns the complex to the GDP bound form, the resting state of G 
proteins. By this mechanism G proteins are thought to serve as molecular 
switches in many regulatory pathways. G proteins can be divided into four 
classes. These are (a) the heterotrimeric G proteins, responding to 
extracellular signals, (b) certain soluble components of the protein synthetic 
machinery Involved in translationai accuracy, (c) proteins related to the ADP-
ribosylation factor ARF, and (d) proteins related to the ras oncoprotein. 
The superfamily of ras-related proteins (Chardin, 1988) is composed of at 
least three subfamilies called Ras, Rho, and Ypt1/Sec4 (called rab in 
mammalian cells), the last one being the most diverse group of the three. 
Approximately 30% of the amino acids are identical among members of 
different subfamilies, and the GTP binding site comprises most of the 
conserved residues (De Vos et al., 1988; Pal et al., 1989). Another Important 
region of the p21'®s.reiated proteins is the carboxy-terminal domain known to 
undergo post-translational modifications essential for attachment of the 
protein to a membrane (Willumsen et al., 1984; Clarke et al., 1988; Lowy and 
Willumsen, 1989; Hancock etal., 1989). 
p2iras.re)ated proteins must serve fundamental roles within cells, because 
most members of this large family are extremely conserved In evolution. For 
Instance, the yeast proteins Yptip, Rasip, and Rholp all have counterparts in 
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mammalian cells that are approximately 70% identical. The specific functions 
of p2iras.related proteins are largely unknown. However, members of the ras 
subfamily are involved in control of cell growth, and in the yeast 
Saccharomyces cerevisiae this function is achieved by stimulation of 
adenylate cyclase (Kataoka et al., 1984; Broek et al., 1985). Increasing 
evidence indicates that members of the ypt family are Involved in several steps 
of intracellular transport (Balch, 1989). 
At least three rho proteins exist in human cells, RhoA, RhoB, and RhoC, 
which are more than 90% identical to each other (Madaule and Axel, 1985; 
Yeramian et al., 1987; Chardin et al., 1988). S. cerevisiae also contains rho 
genes; RH01 is an essential gene that codes for Rholp, the single yeast 
counterpart of the human rhoA, rhoB and rhoC proteins, RH02 codes for a 
nonessential protein 53% Identical to Rholp (Madaule et al., 1987), and 
CDC42 codes for an essential protein 41% identical to Rholp (Johnson and 
Pringle, 1990). Recently, RhoA, RhoC, and presumably RhoB, were shown to 
be substrates of exoenzyme C3 from Ciostridium botulinum (Kikuchi et al., 
1988; Moril et al., 1988; Braun et al., 1989; Chardin et al., 1989; Quilliam et al., 
1989), which catalyses the transfer of ADP-ribose from NAD to a conserved 
asparagine residue at position 41 of RhoA (Sekine et al., 1989). Modification 
by C3 is expected to inactivate Rho proteins, since Asn41 is located within the 
presumed effector site. Mammalian cells subjected to C3 treatment suffer 
alterations of the cytoskeleton, notably a disruption of actin cables (Chardin et 
al., 1989; Petersen et al., 1990). This result suggests that one function of rho 
proteins is to control formation/stability of actin microfilaments. 
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Genetic analyses of mutations in yeast rho genes also indicate a role of 
rho proteins in the determination of cell morphology and stability of the actin 
cytoskeleton. Inactivation of CDC42 or hyperactivation of RH01 causes similar 
morphological defects, namely prevention of bud formation, disruption of actin 
cables, and greatly enlarged cells (Johnson and Pringle, 1990; Johnson, et al., 
1992). This phenotype is very similar to that caused by conditional alleles of 
the actin structural geneACTI (Novick and Botstein, 1985). To gain further 
insight into the molecular mechanisms by which rho proteins control the 
cytoskeleton and cell morphology, the present work was undertaken to 
determine the location of Rholp within yeast cells. 
In the present study we demonstrate that Rholp is by far the most 
prevalent C3 substrate In yeast, and most likely is the only target of this 
exoenzyme. Using C3 modification as a means of detection, Rholp was 
localized primarily to the Golgi apparatus, with a small proportion also found in 
post-Golgi vesicles, suggesting that Rholp functions at the junction between 
these two compartments. Immunofluorescence microscopy performed on 
yeast, using antibodies directed against Rholp, Is then likely to depict the 
Golgi apparatus. 
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MATERIALS AND METHODS 
Media and genetic manipulations 
Nonselective media for yeast contained 1% Bacto yeast extract (Difco 
Laboratories Inc., Detroit, Ml), 2% Bacto peptone (Difco Laboratories Inc.), 
and 2% carbon source, either glucose (YPD) or galactose (YPGal). YPD 
supplemented with 20 mg/liter adenine (YPAD) was used for growth of 
adenine auxotrophs. Selective media contained 0.7% yeast nitrogen base 
without amino acids (Difco Laboratories Inc.), 2% glucose, and auxotrophic 
requirements (uracil, histidine, adenine, leucine, tryptophan) at 20 mg/liter as 
required. Solid media contained 2% agar. Sporulation medium contained 
0.1% glucose and 1% potassium acetate. Dissection of tetrads was 
performed by standard methods (Sherman et al., 1986). Yeast strains were 
transformed with 1-5/x g purified linear or circular plasmid DNA as described 
(Sherman et al., 1986). 
Nucleic acid manipulations 
Recombinant DNA manipulations were performed using standard 
procedures (Ausubel et al., 1989; Sambrook et al., 1989). Oligonucleotides 
were synthesized by the Iowa State University Nucleic Acid Facility (Ames, 
Iowa) using a Biosearch 8750EX automated DNA synthesizer. 
Oligonucleotide directed site-specific mutagenesis was by the method of 
Eckstein (Taylor et al., 1985), using a commercially supplied kit (Amersham 
Corp., Arlington Heights, IL). Nucleotide sequence analysis was by the chain 
termination method (Sanger et al., 1977). E. coli strains HB101 and TG-1 were 
used for amplification of plasmids and/or production of single stranded DNA. 
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Allele and strain constmcù'on 
Construction of the RH01 null allele rho1::HIS3 has been described 
(Madaule et al., 1987). The conditional allele GAL-RHOI was constructed as 
follows. The 1.6-kb EcoRI fragment containing the entire RH01 gene 
(Madaule et a!., 1987) was ligated Into plasmid vector YEp352 (Hill et al., 
1986), and this recombinant plasmid, pMM102, was linearized 350-bp 
upstream of the RH01 coding sequence by digestion with SamHI. The 
promoter region of RH01 was digested with exonuciease Bal31, and EcoRI 
linkers were ligated to the products. Plasmids containing EcoRI inserts of the 
appropriate size were identified by restriction mapping. One such insert was 
transferred to pUCIB to form plasmid pREL-6. Nucleotide sequence analysis 
of this plasmid revealed that the upstream EcoRI site was located six 
nucleotides from the RH01 initiation codon (5'-GAATTCCAGAAAGATG... -3). 
The EcoRI fragment was then ligated into the unique EcoRI site of the 
centromeric plasmid pBMISO (Johnston and Davis, 1984), which is located in 
the GAL10 promoter eight nucleotides upstream of the GAL10 initiation codon. 
The resultant allele Is called GAL-RH01, and the plasmid is pl\4M105, which 
bears the URA3 marker gene. 
Strain MM50 was constructed as follows. The RH01/rho1::HIS3 
heterozygous diploid W303-RH01 (Madaule et al., 1987) was initially 
transformed with pMMIOS. The resulting strain was induced to sporulate, 
meiotic products were separated on YPGal, and colonies were identified that 
required galactose for growth. As expected, these colonies were both 
histidine independent {rho1::HIS3) and uracil independent (pMMIOS). The 
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genotype of one such strain, denoted MM50, was verified by Southern blot 
analysis (data not shown). 
Strain JJ1 was constructed by Integration of GAL-RH01 into the genome 
of wild type strain aW303. A BamH\-EcoR\ partial digestion fragment 
containing GAL-RH01 was prepared from pMM105 and ligated to the 
integrative plasmid vector Ylp352 (Hill et al., 1986) to form plasmid pMM107. 
This plasmid was linearized by digestion at the unique Nco\ site within URA3, 
and used to transform strain aW303 to uracil Independence. Southern 
hybridization analysis confirmed that GAL-RHOI had integrated in the URA3 
locus, as a tandem repeat of 5-10 copies (data not shown). 
Subcellular fractionation methods and enzyme assays 
Yeast cells were fractionated essentially as described by Goud et al. 
(1988). Lysis buffer contained 10 mM triethanolamine pH 7.2,0.8 M sorbitol, 1 
mM PMSF, and a cocktail of protease inhibitors (leupeptin, chymostatin, 
pepstatin, and antipain; Sigma Chemical Co., St. Louis, MO). EDTA was 
omitted from the lysis buffer of Goud et al. (1988) because of its inhibitory 
effect on the efficiency of Rholp labeling by C3. For C3 labeling of particulate 
fractions, PI, P2, and P3 were resuspended in lysis buffer so that equal 
volumes of all differential centrifugation fractions contained the extract from an 
equivalent number of cells. Fractionation of P3 pellets by Sephacryl S-1000 
gel filtration chromatography was as described (Walworth and Novick, 1987). 
The procedure of Ruohola and Ferro-Novick (1987) was used for fractionation 
of P2 or P3 organelles in sucrose density gradients. NADPH cytochrome c 
reductase, vanadate sensitive Mg2+ ATPase, cytochrome c oxidase, and a-
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mannosidase were assayed in the various fractions as described (Ruolioia 
and Ferro-Novicl<, 1987; Walworth and Novick, 1987). Ca2+-dependent 
GDPase (cdGDPase) was assayed by the method of Abeijon et al. (1989). 
Kex2 activity was measured as described by Cunningham and Wickner 
(1989). 
[^P]ADP-ritx)sylab'on of Rholp by exoenzyme C3 
Exoenzyme C3 was prepared from the culture supernatant of C. 
botuUnum strain 1873-D as described (Rubin et al., 1988). C3 labeling 
reactions containing 5 ftl of labeling mixture (60 mM HEPES pH 8.0, 1 mM 
MgCl2,1 mM AMP, 2.5 mM [32p]NAD (50 Ci/mmol; Dupont-NEN, Cambridge, 
MA), 0.3/4g/ml exoenzyme C3, and 5-15 /xl of yeast fraction were Incubated 
for 1 h at 370c, The yeast fractions were total yeast lysates, supernatants SI, 
S2, and S3, pellets PI, P2, and P3 suspended in spheroplast lysis buffer (or 
suspended in and dialysed against lysis buffer), sucrose gradient fractions, or 
Sephacryl S-1000 gel filtration fractions. After the reactions, proteins were 
denatured and separated by SDS-PAGE in 15% acrylamide. Gels were 
stained with Coomassie blue, destained, dried, and subjected to 
autoradiography. Radioactive bands were excised from the gel and cpm in 
each band were measured by scintillation counting. NADase activity in each 
sample was assayed by measuring the hydrolysis of p^pjNAD followed by 
TLC on cellulose plates to identify the reaction products. 
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Production and affinity purification ofanti-Rtiolp antitxxiies 
Polyclonal antisera were raised in rabbits injected with a /8-anthranilate 
(component I) synthase-Rho1p fusion protein produced in £ coli. Using the 
Bal31 digestion method described above, an £coRI site was placed within the 
coding region of RH01, 27 nucleotides downstream from the ATG initiation 
codon. The resultant £coRI fragment, containing most of the RH01 coding 
sequence, was ligated in frame into the E. coli gene trpE of the plasmid vector 
pATH1 (Koerner et al., 1990). The trp promoter of the recombinant plasmid 
was induced as described (Koerner et al., 1990), the fusion protein was size 
fractionated by SDS-PAGE, and acrylamide strips containing this protein were 
crushed in complete Freund's adjuvant and Injected subcutaneously into New 
Zealand white rabbits. Injections of antigen in incomplete Freund's adjuvant 
were repeated after 4, 6, and 11 weeks. Blood samples were taken 1 and 2 
weeks after the latter two injections. 
Antibodies specific for Rho1p were purified from the crude supernatant by 
affinity chromatography using a jS-galactosidase-Rholp fusion protein 
produced in E. coli. To produce this fusion protein, a BglW site was created by 
site-specific mutagenesis immediately following the ATG initiation codon of 
RH01. A DMA fragment extending from this site to a second BglW site 
downstream of RH01 (Madaule et al., 1987) was ligated in-frame to the SamHI 
site of plasmid vector pUR292 (Ruther and Muller-Hill, 1983). This latter site is 
located within the carboxy-terminal coding region of the E. coli gene lacZ. The 
lacZ-RH01 gene fusion was induced from the lac promoter and a total cell 
lysate was prepared (Carroll and Laughon, 1987). The affinity purification 
matrix was prepared by coupling anti-jS-galactosidase antibodies (Sigma 
74 
Chemical Co.) to cyanogen bromide activated Sepharose CL-4B (Pharmacia, 
LKB Biotechnology Inc., Piscataway, NJ), as described by the manufacturer. 
These beads were used to bind jS-galactosidase-Rholp fusion protein from 
the cell lysate, and washed extensively In 10 mM KPO4 pH 7.2,150 mM NaCI 
(PBS). Anti-^-galactosidase antibody and bound fusion protein were then 
chemically crosslinked (Carroll and Laughon, 1987). Crude antiserum from 
rabbits immunized with jS-anthranilate (component 1) synthase-Rholp was 
passed over this affinity matrix, the column was washed extensively with PBS, 
and bound antibodies were eluted in 4 M guanidine-HCI and dialysed against 
PBS. This antibody fraction is denoted anti-Rholp. 
Immunoblotting 
Antibodies against Sec4p and their use in Western blot analysis were as 
described by Goud et al. (1988) using [1251]protein A (Amersham, Les Ulis, 
France). SDS-PAGE gels for immunoblotting using anti-Rho1p were run with 8 
M urea included in the gel. These gels were transferred to nitrocellulose filters 
and probed with anti-Rholp as described (Schmidt et al., 1984). 
Immunofluoresc&nce microscopy 
Cells were grown to early log phase in YPD medium and fixed by addition 
of formaldehyde (3.7% final concentration) directly to the culture. Cells were 
then treated for immunofluorescence microscopy as described (Adams and 
Pringle, 1984; Pringle et al., 1989), using FITC-conjugated goat anti-rabbit IgG 
(Sigma Chemical Co.) as the secondary antibody. Anti-Rholp was bound to 
the cells at a final concentration of 50^g/ml in PBS, 0.2% Triton X-100, 0.1% 
BSA. Preadsorption of anti-Rho1p was performed as follows. Appropriate 
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cells were washed once and resuspended in H2O (1 ml/g wet weiglit cells). 
The suspension was boiled for 40 min, chilled on ice, adjusted to pH 7.3 by 
addition of NaOH, and adjusted to 1x PBS by addition of a 20x PBS stock 
solution (0.025 ml per 1.0 ml lysate). A sample of the boiled cell suspension 
was diluted 10-fold in PBS, 0.2% Triton X-100, 0.1% BSA, and anti-Rholp was 
added to a final antibody concentration of 40 /xg/ml. The mixture was 
incubated for 16 h at 4°C with gentle agitation, after which insoluble cell 
material was separated from the supernatant by three successive 5 minute 
spins at 12,000 x g. The preadsorbed antibody solution was then added to a 
pellet of cells fixed for immunofluorescence analysis, and the remainder of the 
staining and visualization procedures was performed by the standard method. 
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RESULTS 
C3 detects Rholp in S. cerevisiae 
ADP-ribosylatlon of Rholp by C3 was examined In total lysates from yeast 
strains that express RH01 at various levels. Strain MM50 (Table I) contains 
only one functional RH01 coding sequence, which is under control of the 
GAL10 promoter (GAL-RH01). Growth in galactose medium (YPGal) Is 
expected to cause induction of GAL-RHOI, resulting in accumulation of Rholp 
at high levels compared to wild type cells. Conversely, growth of MM50 in 
glucose medium (YPD) should cause repression of GAL-RH01 and 
subsequent depletion of Rholp. Indeed, in YPD medium MM50 divides about 
five times and then ceases growth (data not shown), as expected from the 
finding that RH01 Is an essential gene (Madaule et a!., 1987). Addition of C3 
to wild type cell extracts In the presence of [32p]NAD resulted in transfer of 
ADP-ribose to a protein that migrated as a single radioactive band of apparent 
molecular weight 23 kDa, the predicted size of Rholp (Fig. 1A, lanes 3 and 4). 
MM50 cells grown in galactose displayed a 20-fold increase in labeling of the 
23 kDa substrate as compared to wild type cells, while MM50 cells grown in 
glucose showed only a trace level of the 03 signal (Fig. 1A, lanes 1 and 2). As 
a control, Western blot analysis showed that another p2iras-related protein, 
Sec4p (Salminen and Novick, 1987), is present at about the same levels in wild 
type or MM50 cells grown either in galactose or glucose (Fig. 1B). The data 
indicate that Rholp is the only detectable substrate of C3 in S. cerevisiae. 
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Rholp is located primarily in the Golgi 
The localization of Rholp in S. cerevisiae was studied Initially by 
subcellular fractionation of wild type strain NY13. Cells In late log phase (200 
Aqoo units) were converted to spheroplasts and lysed osmotically. Lysates 
were spun at 450 x g to collect unlysed cells and nuclei, yielding the P1 pellet 
and S1 supernatant. S1 was then centrifuged at 10,000 x g yielding the P2 
pellet, enriched in large organelles, and S2 supernatant. Finally, centrifugatlon 
of S2 at 100,000 x g gave rise to the S3 cytosol fraction and P3 pellet, enriched 
In small organelles. Each subcellular fraction (SI, P1, S2, P2, S3, P3) was 
labeled by ADP-ribosylatlon with C3 (either before or after dialysis to remove 
endogenous NAD) separated by SDS-PAGE, visualized by autoradiography, 
and spots quantltated by scintillation counting. All subcellular fractions were 
also assayed for their enzyme marker content, namely, vanadate sensitive 
Mg2+ ATPase (Bowman and Slayman, 1979; Willsky, 1979) for the plasma 
membrane; Ca2+-dependent GDPase (cdGDPase) (Abeijon et al., 1989) for 
the Golgi apparatus; and Kex2 as a late Golgi marker (Cunningham and 
WIckner, 1989; Julius et al., 1984). As shown in Table II, taking values in the 
81 fraction as 100%, 76% of Rholp is present in P2 and 9% in P3. A 
significant signal is obsen/ed in P1, but since this fraction contains unbroken 
cells and nuclei It was not Included In partition calculations. A signal Is also 
present in S3 (16%), indicating that a proportion of Rholp is cytosolic. The 
fact that the sum of Rholp detected In P2 + S2 equals the S1 value Indicates 
that the 03 ADP-ribosylatlon of Rholp is a quantitative method. Kex2 was 
found to distribute primarily In the P2 fraction. Plasma membrane ATPase and 
cdGDPase show an approximately equal distribution between S2 and P2. A 
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substantial proportion (44%) of the PM ATPase was found in the cytosolic S3 
fraction due probably to solubilization of this enzyme from the particulate form 
during fractionation. 
Rholp was also detected by Western blot analysis using affinity purified 
antibodies reactive with Rholp (anti-Rho1p; see Materials and Methods). 
Induction of the GAL-RH01 gene in galactose medium resulted in a strong 
increase In abundance of a 23 kDa protein recognized by anti-Rho1p (Fig. 2A), 
indicating that the antibodies detect Rholp in total cell extracts. Differential 
centrifugation fractions from wild type yeast were analyzed by Western blot 
analysis (Fig. 2B). In agreement with the C3 labeling results described above, 
the majority of Rholp was detected in P2 with a somewhat smaller amount 
obsen/ed in S2. A minor signal was also detected in the S3 fraction, although 
recovery of Rholp from 82 Into P3 and S3 was not quantitative. Thus, the 
observed distribution of Rholp in differential centrifugation fractions was 
similar in wild type yeast by either immunodetection or C3 labeling. 
The organelles in the P2 pellet were fractionated further by equilibrium 
density gradient centrifugation as described by Goud et al. (1988). Gradient 
fractions were assayed for Rhol p using C3, and also for various enzymatic 
markers specific for the different organelles of the P2 fraction. These markers 
are NADPH cytochrome c reductase (Kreibich et al., 1973; Kubota et al., 1977) 
for the endoplasmic reticulum (ER), vanadate sensitive Mg2+ ATPase for the 
plasma membrane, cytochrome c oxidase (Mason et al., 1973) for the 
mitochondrial inner membrane, a-mannosidase (Van der Wilden et al., 1973) 
for the vacuole membrane, Ca2+-dependent GDPase for the Golgl apparatus, 
and Kex2 for the late Golgi apparatus. Fig. 3 (A and B) shows the results of a 
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typical gradient analysis; these are similar to the profiles of Goud et al. (1988), 
except that one major ER peak was detected instead of the two peaks found in 
the previous study. This discrepancy may reflect slight differences in strains 
or lysis procedures. Migration of Rho1p in the gradients roughly followed the 
cdGDPase Golgi marker (Fig. 3, A and B) and followed very closely the Golgi 
marker Kex2. Clearly, Rho1p migration was distinct from any of the other 
organelle markers (Fig. 3A). Thus, most of the particulate Rho1p appeared to 
be located in the late Golgi apparatus. 
Rholp accumulates on post-Golgl vesicles in certain secretion-ddfective 
mutants 
Temperature-sensitive yeast mutants defective in specific steps of the 
protein transport pathway from the ER to the cell surface (sec mutants; see 
Table I) were used to characterize further the association of Rholp with the 
Golgi apparatus. Three mutants were analyzed in detail both by differential 
centrifugation and equilibrium density gradient fractionation. These are sec18, 
blocked early in secretion (Novick et al., 1980); sec7, blocked at a step in the 
Golgi apparatus; and sec6, blocked late in the secretory pathway and known 
to accumulate post-Golgi vesicles (Novick et a!., 1981). Cells were grown to 
late log phase at 250C in YPD (2% glucose), then shifted to YP medium (0.1% 
glucose) for 2 h at the non-permissive temperature of 370C. Secretion is 
blocked at 370C because of the sec mutation, while the decrease in glucose 
concentration induces synthesis of invertase; thus, the secretory block can be 
followed by assaying invertase activity. In control experiments, growth of wild 
type cells under these conditions did not affect the observed distribution of 
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Rho1p in differential centrifugation fractions, nor its migration during sucrose 
density gradient fractionation (data not shown). 
Differential centrifugation fractions were prepared from the three mutants 
as described above, and Rho1p abundance in each fraction was determined 
by C3 labeling. In all three mutants the total amount of Rho1p in the 
particulate fractions (i.e., P2 + P3) was about the same as that found in wild 
type cells (Table III). Migration of Rholp and the enzymatic markers during 
density gradient fractionation of P2 from sece, sec1d, or sec7 was very similar 
to that shown for wild type cells in Fig. 3 (data not shown). In sec18 and sec7 
the distribution of Rholp between P2 and P3 was similar to wild type (Table 
III). However, in the sec6 mutant a large increase in the abundance of Rholp 
was found in the P3 fraction, with a concomitant decrease in P2 (Table III). 
This result suggests that Rholp is located on post-Golgi vesicles as well as in 
the Golgi apparatus. 
To test this hypothesis, P3 fractions from sec6 were fractionated further 
by centrifugation to equilibrium in sucrose density gradients. Each gradient 
fraction was assayed for (a) Rholp, (b) invertase, which accumulates in post-
Golgi vesicles in the thermosensitive mutant strain sec6 (Novick et al., 1981), 
and (c) Sec4p, a marker of post-Golgi vesicles (Goud et al., 1988). Sec4p was 
identified in the gradient fractions by Western blot analysis. The invertase 
peak lies just between the peaks of Rholp and Sec4p consistent with a post-
Golgi vesicle localization for these proteins (Fig. 4). Rholp clearly migrated to 
a slightly lighter density than that of Sec4p (Fig. 4), suggesting that these two 
proteins are associated with different kinds of secretory vesicles. The density 
of Rho1 p-bearing vesicles was identical in sec6 and NY13 (data not shown). 
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Material in tlie P3 pellet of sec6 also was fractionated on tlie basis of size 
using gel filtration chromatography (Walworth and Novick, 1987). Fractions 
were assayed as described above for invertase, cdGDPase, Kex2 activity, 
Rholp, and Sec4p, as well as for total protein concentration. The post-Golgi 
vesicle marker invertase eluted from the column in a peak reaching a 
maximum at fraction 24 (Fig. 5). The Rholp elution profile followed exactly 
that of invertase which suggests that Rholp is indeed bound to post-Golgi 
vesicles. The Kex2 peak was shifted slightly towards the smaller size range 
compared to that of both Rholp and Sec4p (Fig. 5). 
Since the normal subcellular location of Rholp is altered in sec6, other 
secretory mutants known to accumulate post-Golgi vesicles were examined 
for the distribution of Rholp in the SI, 82, P2, S3, and P3 fractions. P1, P2, 
and P3 pellets were prepared as described, except that 40 OD units of cells 
were used for each strain. Invertase activity was determined in the P2 and P3 
fractions from each mutant, demonstrating that in all cases an efficient 
secretory block had been obtained (data not shown). 03 labeling indicated 
that, in addition to sec6, the sec2, and sec4 mutants also underwent a major 
redistribution of Rholp to the P3 pellet (Table IV). A less striking redistribution 
between P2 and P3 was also observed in the seed, secIS, and seel mutants. 
No redistribution was detected for sec3, however, the secretion block In sec3, 
as measured by invertase accumulation, was only twice that of the wild type 
strain. Thus, a redistribution of Rholp to the vesicle fraction is observed in at 
least six out of seven mutants known to accumulate post-Golgi vesicles. 
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Localization ofRholp by immunofluorescence microscopy 
Anti-Rho1p was used to detect Rho1p in wild type strains NY13 and 
aW303 by indirect immunofluorescence microscopy. Fig. 6 (A and B) shows 
that the antibodies detect a pattern of dots which appear to be concentrated 
towards the periphery of the cell and in the bud. As a control experiment to 
test specificity of this staining pattern, anti-Rho1p was preadsorbed with yeast 
lysates from cells that either were depleted of Rho1p or over accumulated this 
protein (see Materials and Methods). As shown in Figs. 1 and 2, growth of 
strain MM50 in glucose medium resulted in depletion of Rho1p to trace levels, 
while growth of strain JJ1 In galactose medium caused accumulation of Rho1p 
to very high levels. Preadsorption of the antibodies with glucose-grown MM50 
cell material did not alter the immunofluorescence staining pattern from that 
found with untreated antibodies (Fig. 6D). However, preadsorption with the 
same concentration of galactose-grown JJ1 cell material completely 
eliminated the dotted staining pattern (Fig. 6C). Therefore, the dots appear to 
be specific to Rho1p, and not due to nonspecific interactions such as 
antibodies adhering to the cellular membrane. 
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DISCUSSION 
Exoenzyme 03 from C. botulinum strains C and D is known to ADP-
ribosylate the mammalian OTP binding proteins RhoA and RhoO, and 
presumably also modifies RhoB (Chardin et al., 1989). Amongst the three Rho 
proteins known in S. cerevisiae, Rho1p, Rho2p, and Cdc42p, the former is by 
far the most closely related to RhoA, RhoB, and RhoC, with identities at -70% 
of the amino acids (Madaule et al., 1987). Therefore, Rholp was expected to 
be the 23 kDa protein previously Identified as a substrate of C3 in this 
organism (Chardin et al., 1989). A recent report (Didsbury et al., 1989) 
suggests that C3 also modifies two newly discovered human proteins related 
to rho, termed raci and rac2 (rac stands for "ras substrate for C3"). Rac 
proteins share 70% identities with the Cdc42p protein of S. cerevisiae 
(Johnson and Pringle, 1990) and thus may be considered as the mammalian 
counterparts of this yeast protein. Thus, Cdc42p was also expected to be 
modified by 03. However, almost no ADP-ribosylation by C3 was observed in 
strain MM50 grown in conditions where expression of the RH01 coding 
sequence is repressed, demonstrating that Rholp is the sole detectable 
substrate for 03 in yeast. Other substrates, if they exist, are either present at 
very low levels compared to Rhol p, or are very poor substrates for 03 in our 
experimental procedure. In any case, 03-mediated ADP-ribosylation is a 
reliable means of assaying Rholp In yeast lysates. 
Using 03 to measure the abundance of Rholp in subcellular fractions, 
most of the Rholp in wild type yeast appeared to be located within the Golgi 
apparatus. In support of this observation a small OTP binding protein ADP-
ribosylated by a preparation defined as "botulinum toxin" has been shown to 
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be associated with the Golgl apparatus in rat liver cells (Toki et al., 1989). 
Rho1p was detected primarily in the P2 pellet which is enriched in large 
organelles. In density gradient fractionation of these organelles, Rho1p was 
found to colocalize with Kex2 activity, a late Golgl marker. Rho1p in the 
density gradients was not associated with enzymatic markers of the 
mitochondria, vacuole, plasma membrane, or endoplasmic reticulum. 
Mutations that cause accumulation of secretory vesicles, derived from the 
Golgi, result in the redistribution of Rho1p to the vesicle fraction., These 
observations suggest strongly that Rho1p resides in the Golgi apparatus. The 
data do not rule out, however, that a minor fraction of Rho1p may also be 
associated with another membrane in addition to the Golgi. 
About 9% of the particulate Rholp in wild type cells was detected in the P3 
pellet, which is enriched in small organelles. For the following reasons the 
Rholp-bearing material appeared to be an authentic vesicle, as opposed to 
broken Golgi that contaminates P3. The Rholp-bearing organelle in P3 has a 
size similar to that of secretory vesicles. In the secretory mutants sec2, sec4, 
sec6, sec8, and sec 15, grown in conditions where they accumulate post-Golgi 
vesicles, a large amount of Rholp was found in the P3 pellet. Conceivably, 
these sec mutations could alter the Golgi apparatus indirectly, so that partial 
breakage of this organelle occurs during fractionation. However, artifactual 
breakage of the Golgi apparatus is unlikely to account for the significant 
increase in Rholp found in the P3 fractions of sec2, sec4, or sec6. In 
addition, the vesicle bearing Rholp that accumulates in sec6 has precisely the 
same elution profile as the invertase containing vesicle. Thus, Rholp 
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appeared to be bound to a physiological vesicle that accumulates in these late 
secretory mutants. 
What Is the nature of the Rho1p-bearing vesicles? The most likely 
explanation is that these are post-Golgi vesicles, since they accumulate in 
most late secretory mutants. Hov/ever, not all of the post-Golgi sec mutants 
exhibit the same shift of Rho1p from P2 to P3. The precise defects leading to 
accumulation of post-Golgi vesicles are not known, however, it is possible that 
some sec genes code for proteins that function shortly after secretory vesicles 
leave the Golgi apparatus (early post-Golgi vesicles). These mutations could 
also affect the localization for example of Rho1p on early post-Golgi vesicles. 
A second possibility is that Rho1p resides entirely within the Golgi 
apparatus, and that Rho1p-bearing vesicles are involved in transitions 
between Golgi saccules. However, the fact that Rho1p accumulates in the 
vesicular fraction of certain late secretory mutants along with Sec4p and 
Invertase favors the interpretation that Rho1p-bearing vesicles are post-Golgi 
vesicles. 
A model for Rho1p localization is depicted in Fig. 7. A substantial amount 
of Rho1p would reside on trans-Golgi membranes. A small proportion of the 
Rho1p pool would leave this organelle bound to membranes, as part of the 
early post-Golgi vesicles. In what could be envisaged as a maturation 
process, Rho1p would return to the Golgi apparatus, possibly as a cytosolic 
intermediate, while the post-Golgi vesicles would acquire their final size and 
density, and would bear Sec4p. This model is consistent with the fact that 
Rho1p is located both in the Golgi apparatus and in post-Golgi vesicles, while 
Sec4p resides both in post-Golgi vesicles and the plasma membrane (Goud et 
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al., 1988). This model also explains the slightly different physical 
characteristics observed for the Rho1p- and Sec4p-bearlng vesicles. The 
possibility that vesicles leaving the trans-Qolgi are different from those arriving 
at the plasma membrane has already been hypothesized (Payne and 
Schekman, 1989). According to one model proposed by Payne and 
Schekman (1989), clathrin coated vesicles leave the trans-Golgi and form a 
retrieval compartment for Golgl enzymes. Secretory vesicles could be 
generated from this retrieval compartment and sent to the plasma membrane. 
The data does not distinguish between the possibilities that Rholp and Sec4p 
are located on entirely distinct populations of vesicles, or, alternatively, 
whether some intermediate vesicles contain both proteins. 
Immunofluorescence of wild type yeast was performed using affinity 
purified polyclonal antibodies directed against Rholp. A pattern of small dots 
was obsen/ed at the periphery of the cell, with more intense labeling in the 
bud. Since wild type cells were used in this analysis, most of the Rholp is 
expected to be in the late Golgl apparatus. Very little information is available 
from the literature about the structure of the Golgl apparatus in S. cerevisiae. 
Immunofluorescence detection of the Golgi protein Ypt1p (Segev et al., 1988) 
revealed a pattern similar to that of Rholp, except that the Ypt1p dots are 
larger, and are located further Inside the cell. However, Ypt1p Is likely to 
reside on the cis-GoIgi (Bacon et al., 1989; Baker et al., 1990). The anti-Rho1p 
immunofluorescence result, taken together with the subcellular fractionation 
data, suggest that the Golgi of S. cerevisiae consists of small saccules located 
close to the periphery of the cell. 
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An important question is to relate the subcellular location of Rho1p to its 
function. Secretion of invertase was assayed in a rho1 mutant strain, and no 
striking differences were observed either in the internal or external pools of 
enzyme (our unpublished observations). Therefore, Rho1p appears to 
function in a process other than enzyme export. Previous studies suggested 
that the mammalian counterparts of Rho1p are needed for assembly of actin 
filaments (Chardin et al., 1989; Paterson et al., 1990). In S. cerevisiae, rho1 
mutants (Johnson et al., 1992) appeared very similar to a group of cell division 
cycle mutants, including CDC24, CDC43, and the rho-relaXed gene CDC42 
(Pringle and Hartwell, 1981; Sloat et al., 1981). All of these conditional mutants 
are unable to form buds, develop into greatly enlarged cells, and display 
abnormalities in the cytoskeleton typical of some actin mutants. Location of 
Rho1p in the Golgi apparatus Is not surprising, given that it functions in bud 
formation. Most secretory vesicles are directed toward the site of bud 
formation, to build additional plasma membrane. The Golgi and post-Golgi 
vesicles are likely organelles to regulate the structure of newly synthesized 
plasma membrane, which should develop into a bud only when required. Bud 
formation could be regulated by modifying the structure and/or composition 
of integral membrane proteins in future plasma membrane, which already are 
present in post-Golgi vesicles. This process could include a modification of 
the nascent bud site required for attachment of actin microfilaments, thus 
explaining the observed effect of rho proteins on actin structure. 
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TABLES 
Table I. Yeast strains 
Strain Genotype Source 
IVIMSO Mata, ura3, Ieu2, hls3, trp1, ade2, can1, This study 
rho1::HIS3 (URA3, CEN4, GAL-RH01) 
aW303 Mata, Ieu2, his3, ura3, trp1, ade2 R. Rothstein, 
(Columbia University) 
This study 
P. Novick, 
(Yale University) 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
P. Novick 
JJ1 Mata, Ieu2, his3, trp1, ade2, can1, 
URA3::GAL-RH01* 
NY13 MATa, ura3-52 
NY3 MATa, ura3-52, sec1-1 * 
NY130 MATa, ura3'52, sec2'56 
NY412 MATa, ura3-52, sec3-2 
NY405 MATa, ura3-52, sec4-2 
NY17 MATa, ura3-52, siec6-4 
NY176 MATa, ura3-52, sec7-1 
NY410 MATa, ura3-52, sec8-1 
NY430 MATa, ura3-52, sec14-3 
NY64 MATa, ura3-52, sec15-1 
NY432 MATa, ura3-52, sec18-1 
* Approximately 10 copies of GAL-RH01 are integrated at the URA3 locus. 
* These strains are called respectively seel, sec2, sec3, etc. in text. 
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Table H. Percent Rho1p and marker distribution in wild type yeast NY13 
Fraction Rho1p PM ATPase cdGDPase Kex2 
S1 100 100 100 100 
P2 76 38 47 82 
S2 21 60 57 41 
P3 9 15 41 40 
S3 16 44 0 41 
Total for 
P2+S2 97 98 104 123 
Estimation of Rho1p content by C3 ADP-rIbosylation was Identical after 
dialysis to remove endogenous NAD. Weak NADase activity could be 
detected in S1, S2, and S3 fractions. 
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Table III. Percent distribution in mutants of the secretory pathway 
Strain 
Secretory 
block point 
Fraction 
S1 S2 P2 S3 P3 
NY13 None 100 21 80 9 12 
seel 8 ER to Golgl 100 22 78 10 16 
sec7 Golgl 100 28 71 4 24 
sec6 Golgi to PM 100 47 47 9 43 
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Table IV. Percent Rholp distribution In post-Golgi secretory mutants 
Strain S1 S2 P2 S3 P3 
NY13 100 21 76 9 16 
sec6 100 47 47 9 43 
sec2 100 51 49 10 50 
sec3 100 25 72 8 20 
sec4 100 41 70 9 42 
sec8 100 30 70 . 10 26 
sec15 100 33 67 9 30 
seel 100 31 69 10 28 
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FIGURES 
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Figure 1. Rholp is the major substrate for C3 in yeast. MM50 or NY13 (WT) 
strains were grown on rich medium either with 2% glucose or 2% galactose to 
an ODgoo nm = ''• Spheroplasts were prepared from 4 Aeoo units of culture, 
resuspended in 100^1 of lysis buffer. Lysates were obtained after four cycles 
of freeze-thawing. Aliquots (15/tl) were ADP-ribosylated by C3 as described 
in Materials and Methods and analyzed by 15% SDS-PAGE and 
autoradiography. 20 ^1 aliquots of the same preparations were also 
elèctrophoresed on 15% SDS-PAGE and transferred to nitrocellulose which 
was incubated with rabbit anti-Sec4p antibodies (diluted 1:1,000). The Sec4p 
was then detected by incubation of the Western blot with protein A. (A) 
ADP-ribosylation by C3. (B) Sec4p Western blot. Lanes 1 and 2 correspond 
to the MM50 strain and lanes 3 and 4 to the wild type strain. Preparations in 
lanes 1 and 3 were grown in media with glucose as the carbon source, 
whereas those in lanes 2 and 4 were grown in media with galactose as the 
carbon source. The autoradiogram was deliberately overexposed to detect 
other possible substrates for C3 in lysates. Molecular mass standard sizes 
are indicated in kilodaltons. 
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Figure 2. Detection of Rho1p by Western blot analysis. (A) JJ1 cells were 
grown to mid-log phase (0.5-1.0 X 10® cells/ml) in liquid YPD medium. Cells 
were then pelleted from the medium, washed once in YPGal, resuspended in 
YPGal at the original cell concentration, and returned to a shaker at 30oc. 
Samples of the culture were removed at various times thereafter, and total 
protein extracts were prepared and separated by SDS-PAGE in the presence 
of 8 M urea (10 /tg protein/lane). The proteins were transferred to 
nitrocellulose filters and probed with anti-Rho1p. (B) Differential centrifugation 
fractions were prepared from wild type strain aW303 and analyzed as in A. 
Extracts from an equivalent number of cells were loaded in each lane, with 30 
HQ protein loaded for the SI fraction. 
Figures. Rho1p comigrates with the Kex2 marker in P2 gradients. The P2 
pellet was resuspended in 60% sucrose (2 ml) and loaded on the bottom of 
a 35-60% sucrose gradient. After centrifugation to equilibrium, gradients 
were fractionated from the top in 500 /tl fractions and labeled 1-25. For 
each fraction, the different enzyme markers were assayed as well as 
Rho1p by C3-mediated specific ADP-ribosylation. For Rho1p estimation, 
15/xl aliquots of each fraction were incubated with C3 under tiie conditions 
described in Materials and Methods followed by 15% SDS-PAGE and 
autoradiography. Radioactive spots were cut out and counted for 
quantitative estimation and expressed in total cpm. Sucrose density is 
expressed in grams percent. Protein concentrations were estimated by the 
standard Bradford assay and results are expressed as absorbance at 595 
nm. NADPH cytochrome c reductase (endoplasmic reticulum) absorbance 
at 550 nm. cdGDPase (Golgi) absorbance at 660 nm (A and B). ATPase 
(plasma membrane) absorbance at 710 nm. Cytochrome c reductase 
(mitochondria) absorbance at 650 nm. a-mannosidase (vacuole) 
absorbance at 400 nm. Kex2 activity (late Golgi) fluorescence emission at 
460 nm. A and B represent two independent experiments. 
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Figure 4. Analysis of Rholp and Sec4p in the P3 pellet of sec6 cells by 
sucrose density gradients. PS pellets were prepared by differential 
centrifugation from sec6 strain (shifted to 37°C in 0.1% glucose) and 
resuspended in 2 ml of 60% sucrose and loaded on the bottom of a 35-60% 
sucrose gradient. Rholp was assayed by C3 ADP-rlbosylation, 15% SDS-
PAGE analyses, and autoradiography using ^5 n\ aliquots as described in 
Materials and Methods. Sec4p was monitored by Western blot analysis and 
quantified by measurement of radioactive spots. Invertase was measured as 
described previously (Goldstein and Lampen, 1975). Sucrose density is 
expressed in percent values. 
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Figure 5. Rho1p bearing vesicles are of the same size as invertase containing 
vesicles from sec6 strain. 35 4-ml fractions were collected from a Sephacryl S-
1000 column as described in Materials and Methods. Each fraction was 
assayed for Rho1p, Ca2+-dependent GDPase, Sec4p, invertase, and protein 
concentration (Bradford). The results are expressed as cpm or OD. 
Figure 6. Localization of Rho1p by immunofluorescence microscopy. Wild 
type cells were grown in YPD to early log phase, and processed for 
immunofluorescence microscopy using anti-Rho1p at a concentration of 
40 ftg/ml. (A) NY13; (B) aW303; (C) aWSOS, anti-Rho1p preadsorbed 
with a lysate from JJ1 cells grown in galactose (depleted of Rho1p 
antibodies); (D) aWSOS, antl-Rho1p preadsorbed with a lysate from MM50 
cells grown in glucose (not depleted of Rho1p antibodies). 
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Figure 7. Model for Rholp localization. 
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ABSTRACT 
The p21 ras-related protein Rho1p Is a negative regulator of bud 
emergence in the yeast Saccharomyces cerevisiae. Rholp Is located in the 
Golgl apparatus and post-Golgi vesicles present at the cell's periphery. In the 
current study, Rholp was partially purified from yeast cells and characterized 
regarding Its guanine nucleotide binding and hydrolysis properties. Rholp 
was obtained with a 0.11% yield in a 25-fold purification. Rholp bound GTP 
with rates of 0.08, 0.10, and 0.034 pmol GTP bound/pmol Rholp/min at free 
magnesium concentrations of 0.2^M, 50nM, and 10 mM, respectively. The 
protein displayed intrinsic GTPase specific activity of 0.021, 0.032, and 0.028 
pmol P| released/pmol Rholp/min, respectively, at these same free 
magnesium concentrations. At a free magnesium concentration of 0.2/xM the 
GTPase activity of Rholp was increased approximately 1.5-fold by addition of 
glutathione S transferase-Bem2p. This fusion protein comprises part of the 
BEM2 gene product, another gene known to be involved in the process of bud 
formation. Thus, Bem2p is a GTPase activating protein (GAP) for Rholp. This 
finding is consistent with genetic the characterizations of the roles of RH01 
and BEM2 in bud emergence. 
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INTRODUCTION 
This study addresses the biochemical properties of Rho1p, a member of 
the large family of p21''as-related proteins. Eukaryotic cells typically contain 
multiple members of this protein family, ras genes were first identified as the 
transforming factors of the Harvey and Kirsten strains of rat sarcoma viruses, 
and activated forms of ras genes have subsequently been found in 
approximately 40% of all human tumors (Barbacid, 1987). The ras gene 
superfamily is highly conserved throughout evolution, as can be seen by the 
high percentage of homology between specific ras-related genes In highly 
divergent organisms (Valencia et al., 1991). Thus, ras-related genes are likely 
to have fundamental roles in basic cellular functions. 
All p21'^ s.reiated proteins characterized to date are guanine nucleotide 
binding proteins (G proteins), possess intrinsic GTP hydrolysis (GTPase) 
activity, and associate with a cellular membrane (Barbacid, 1987). Modified 
p2iras proteins capable of oncogenic transformation have reduced GTPase 
activity, indicating the proteins are active when bound to GTP, and inactive 
when bound to GDP (Barbacid, 1987). p2iras in its active conformation is 
thought to interact with an effector molecule. This interaction may bring about 
the hydrolysis of GTP into GDP, returning the protein to its inactive 
conformation. Proteins capable of increasing the GTP hydrolysis activity of 
p2iras termed GAPs, have been identified (Trahey and McCormick, 1987). 
Alternatively, GAP proteins may function to down regulate p2iras activity, and 
not be the actual effector molecule (Hall, 1990). 
Rho genes code for proteins approximately 30% identical to p2iras, and 
thus make up a subfamily of the ras-related superfamily. The rho gene was 
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first identified in a cDNA library from the abdominal ganglia of the marine snail 
Aplysia oalifornica (Madaule and Axel, 1985). Three rho genes have been 
described to date in S. cerevisiae, namely RH01, RH02, and CDC42 
(Madaule et al., 1987; Adams et al., 1990; Johnson et al., 1990). RH01 and 
RH02 are 70% and 57% identical at the amino acid level to A. oalifornica riio, 
respectively, and the two yeast genes are 53% identical to each other. RH01 
is an essential gene in yeast, whereas RH02 is not required for cell viability. 
The lethality of inactivation of RH01 cannot be suppressed by the 
overproduction of a yeast ras protein, or the catalytic subunit of cAMP-
dependent protein kinase, indicating ras and rho genes function in 
independent pathways (Madaule et al., 1987). 
Highly conserved counterparts of RH01 and CDC42 are present In 
mammals, coding for proteins 70-80% identical at the amino acid level to the 
corresponding yeast proteins. The mammalian RH01 homologs are called 
rhoA, rhoB, and rhoC (Madaule and Axel, 1985; Chardin et al., 1988; Yeramian 
et al., 1987), and the CDC42 protein equivalents are termed Gp, G25K, Raci, 
and Rac2 (Didsbury et al., 1989; Polakis et al., 1989; Munemitsu et al., 1990). 
Thus, the biochemical function of Rho proteins is likely to be conserved in 
evolution, as has been demonstrated for the CDC42 gene product and G25K 
(Munemitsu etal., 1990). 
Previous studies have shown Rholp is located in the Golgi apparatus and 
secretory vesicles present at the cell's periphery (McCaffrey et al., 1991). 
Furthermore, genetic analysis showed Rholp functions as a negative 
regulator of morphological development in the cell cycle, preventing bud 
emergence when overexpressed (Johnson et al., 1992). The spectrum of 
115 
phenotypic characteristics caused by RH01 overexpression can also be 
caused by the r/70-related gene CDC42, as well as the yeast genes CDC24, 
CDC43, BEM1, and BEM2 (Sloat et al., 1981; Adams et al., 1990; Johnson and 
Pringle, 1990; Bender and Pringle, 1989; Bender and Pringle, 1991). RH01, 
however, is the only member of this group with a negative effect on bud 
emergence. 
To gain more insight on how Rholp functions in regulation of cell cycle-
related morphological development, it was purified from a yeast strain 
expressing \he RH01 coding region from the strong, inducible promoter of the 
yeast gene GAL10. Determination of Rholp's guanine nucleotide binding and 
hydrolysis properties showed rates of GTP binding and GTPase activity 
comparable to those of other p2iras.related proteins. These activities also 
displayed dependence on magnesium ion concentration, similar to previously 
characterized ras gene products. A GAP protein active on Rholp was 
identified as the product of BEM2, a gene known to be involved in the process 
of bud emergence. 
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MATERIALS AND METHODS 
Oveqxoduction ofRholp in yeast 
The construction of the Rholp-overproduclng strain JJ1 was described 
elsewhere (Johnson et al., 1992; McCaffrey et al., 1991). This strain contains 
multiple copies of GAL-RH01, a hybrid gene in which the GAL10 promoter 
region extending to eight nucleotides upstream of the GAL 70 initiation codon 
was fused to RH01 beginning seven nucleotides upstream of its initiation 
codon. Thus, in strain JJ1, RH01 is expected to be expressed from the 
GAL10 promoter at very high levels in the presence of galactose. JJ1 cells (8 
I) were grown to early log phase in rich glucose medium (YPD; 2% peptone, 
1% yeast extract, 2% glucose), collected by centrifugation, washed once with 
rich galactose medium (YPGal; 2% peptone, 1% yeast extract, 2% galactose), 
and resuspended in YPGal at the original cell concentration. After 24 hours at 
30OC cells were collected by centrifugation and resuspended in start buffer 
(0.025 M histidine-HCI pH 6.15,1 mM MgCy supplemented with 1 mM DTT, 1 
mM PMSF, and 1 /tg/mi of each of the following protease inhibitors: antipain, 
aprotinin, chymostatin, ieupeptin, and pepstatin A. Cells were then lysed by 
agitation with glass beads using the Bead-beater (Biospec Products, 
Bartlesville, OK), surrounded in ice, in eight inten/als of 30 seconds each. The 
lysate was then spun at 500 x g to remove unbrol<en cells, at 10,000 x g to 
remove organelles and large membrane fragments, and at 100,000 x g to 
prepare the total soluble fraction. The supernatant was stored at -70°C until 
use. 
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Purification of Rholp 
Approximately 300 mg of total soluble protein from induced JJ1 cells was 
loaded onto a 30 ml bed volume chromatofocusing column containing PBE 94 
matrix (Pharmacia LKB Biotechnology inc., Piscataway, NJ) equilibrated in 
start buffer. The pH gradient was formed using Polybuffer 74-HCI pH 4.0 as 
the eluent. Fractions containing QTP binding activity and Rholp 
immunoreactivity (see below) were combined and concentrated to 
approximately 20 ml by ultrafiltration using Centriprep-10 filter units (Amicon, 
Beverly, MA). This material was then applied to a 480 ml bed volume Bio-Gel 
P-60 gel filtration column (Bio-Rad Laboratories, Richmond, CA). The column 
was eluted in TMDN buffer (20 mM Tris-HCI, pH 8.0, 5 mM MgCl2,1 mM DTT, 
0.1 M NaCI). The fractions containing GTP binding activity and Rholp 
immunoreactivity were combined, concentrated to approximately 0.5 ml using 
Centriprep-10 filter units, and used in all subsequent analyses. 
G7P t)inding assay 
Guanine nucleotide binding activity was measured by a rapid filtration 
technique (Kabcenell et al., 1990). For assay of guanine nucleotide binding in 
chromatographic fractions samples of the eluent were incubated with 0.5 nM 
[a-32p]GTP (40,000 cpm/pmol, ICN Biomedicals Inc., Costa Mesa, CA) in 400 
ftl HB buffer (50 mM HEPES pH 8.0, 200 mM NaCI, 2.5 mM EDTA, 1.0 mM 
DTT, 0.1 mg/ml BSA) at 370C for 90 minutes. The concentration of 
magnesium was adjusted by the addition of either EDTA or MgClg. Free 
magnesium was calculated according to Sunyer et al. (1984). The reaction 
was stopped by the addition of 1.0 ml ice cold SB buffer (20 mM Tris-HCI, pH 
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8.0, 100 mM NaCI, 25 mM MgCy, filtered tlirough 25 mm diameter BA85 
nitrocellulose filters (Schleicher & Schuell, Keene, NH), and washed twice with 
5 ml SB buffer. The filters were dried, 5 ml ScintiVerse BD scintillation fluid was 
added, and radioactivity was quantitated by scintillation counting. Similar 
assays were used to measure guanine nucleotide binding activity of purified 
Rho1p, except that the GTP concentration was 2.0 ^ M. These assays were in 
a total volume of 600/tI, with 100^1 aliquots removed at various time intervals. 
GTPase assay 
GTPase activity was monitored by the release of free phosphate upon 
incubation of Rholp with [y-^^pjGTP. Rholp was incubated with 1 /nm [7-
32p]GTP (100,000 cpm/pmol; ICN) in 100^1 HB buffer. At 15 minute intervals, 
10 ft I aliquots were removed and added to 750/t I ice cold 50 mM NaH2P04, 
5% charcoal. The reactions were mixed by inversion. This resulted in the 
proteins and guanine nucleotides being trapped by the charcoal while 
inorganic phosphate remained in the soluble phase. The mixtures were spun 
at 1,400 x g for 10 min, 500 ft I of the supernatant was removed and added to 5 
ml of ScintiVerse BD scintillation fluid, and radioactivity was quantitated by 
scintillation counting. 
Miscellaneous methods 
Immunodetection of Rholp by Western blot analysis (Towbin et al., 1979) 
was performed as described by Schmidt et al. (1984) using affinity purified 
anti-Rholp antibodies (McCaffrey et al., 1991). Protein concentrations were 
determined by the method of Bradford (1976). 
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RESULTS AND DISCUSSION 
Overe)^)ression and purificaUan c^Rholp 
Rholp was purified from yeast strain JJ1, tlie construction of which is 
described eisewhere (Johnson et al., 1992; McCaffrey et al., 1991). In 
summary, the fusion gene GAL-RH01 was integrated by homologous 
recombination at the chromosomal URA3 locus. Southern hybridization 
analysis showed that multiple copies of GAL-RH01 had Integrated as tandem 
repeats. Upon induction of the GAL10 promoter in rich galactose medium 
(YPGai), there was approximately a 100-fold increase in the level of Rholp as 
determined by immunobiot analysis with Rhol p-specific antibodies (McCaffrey 
et al., 1991). The amount of guanine nucleotide binding activity In a 100,000 x 
g supernatant from JJ1 cells increased 40-fold following exposure to 
galactose. This high level of activity was due to RH01 specifically, because it 
was only present in JJ1 after induction of GAL-RH01, and It was not present in 
a wild type strain (data not shown). This soluble supernatant was used in the 
purification of Rholp. 
Proteins in the high speed supernatant were first fractionated based on 
their isoelectric points by the method of chromatofocusing. Rholp eluted in a 
single peak from pH 5.0 to pH 4.7, as shown by GTP binding assays and 
immunobiot analysis (Fig. 1 and 2). In a control experiment the guanine 
nucleotide binding activity in these fractions was reduced approximately 40 to 
50-fold in analysis of extracts from wild type ceils expected to produce normal 
levels of Rholp (data not shown). Thus, the activities derived from 
fractionation of JJ1 cells are due specifically to Rholp. The fractions 
containing Rholp were combined, concentrated by ultrafiltration, and applied 
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to a Bio-Gel P-60 gel filtration column. Two peaks of GTP binding activity were 
eluted (Fig. 3), and both were immunopositlve when screened with the Rholp-
specific antibodies (data not shown). 
The higher molecular weight peak of Rho1p Is believed to contain an 
aggregated form of the protein. Further evidence for this conclusion was 
obtained during analysis of Rho1p in soluble extracts of strain JJ1 after 
induction of GAL-RH01. Western blot analysis showed, as expected, 
induction of a 23 kDa form of Rholp in SDS-PAGE. Additional forms of Rho1p 
were also detected by immunoblot analysis, all of which were of higher 
apparent molecular weights (McCaffrey et al., 1991). None of these additional 
signals were detected in JJ1 prior to induction of GAL-RH01. The prevalence 
of the high molecular weight forms was reduced when SDS-PAGE was 
performed in the presence of 8 M urea, and when protein was applied to the 
gels at lower concentration (data not shown). The reason why Rholp remains 
aggregated even after boiling in the presence of SDS is not clear. The smaller 
molecular weight Rholp species eluted from the gel filtration column is 
believed to be the monomeric form of the protein. The fractions containing the 
small molecular weight Rholp species were combined and concentrated by 
ultrafiltration, and used in all subsequent analyses. 
The results of a typical purification of Rholp are shown in Table 1. An 
average yield of approximately 0.1 mg was obtained from a 21 culture. Rholp 
was purified approximately 25-fold with a yield of 0.11%. This low yield is 
similar to those values obtained when rho proteins have been purified from 
other sources (Anderson and Lacal, 1987; Yamamoto et al., 1988; Morii et al., 
1988; Braun et al., 1989; Hoshijima et al., 1990). 
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Guanine nucieoù'de binding acUviiy 
The association of guanine nucleotides with G proteins has been found to 
be dependent on magnesium concentration (Hall and Self, 1986). The 
magnesium dependence of guanine nucleotide binding by Rholp was 
determined by the filter binding technique. The on rate of GTP binding at 0.2 
/iiyi, 50nM, and 10 mM free magnesium was 0.08, 0.10, and 0.034 pmol GTP 
bound/pmol Rholp/min, respectively (Fig. 4). A decreased on rate at high 
free magnesium concentrations was observed previously for p2lN-ras (Hall 
and Self, 1986). 
GTPase acUvhy 
The intrinsic GTP hydrolysis activity of Rholp is shown in Fig. 5, as 
determined by monitoring release of free phosphate upon incubation of the 
protein with fy-^^pjGTP. GTP hydrolysis activity was measured at various free 
magnesium concentrations. The GTPase specific activity of Rholp was 
determined to be 0.021, 0.032, and 0.028 pmol P| released/pmol Rho1p/min, 
respectively, at free magnesium concentrations of 0.2/iM, 50/xM, and 10 mM. 
These values approximate the specific activities obtained with a rho protein 
purified from a mammalian source (0.01 min-i; Yamamoto et al., 1988) and 
also the specific activity typically obtained for ras proteins (approximately 0.02 
min'i;Bourne et al., 1990), however, they are somewhat higher than other 
p2iras.related proteins such as Sec4p (0.001 min-i; Kabcenell et al., 1990), 
and rap2 (0.005 min-i; Lerosey et al., 1991). 
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Identification of a GAP for Rholp 
Heterotrimeric G proteins typicaily display GTP hydrolysis rates 
approximately 100-fold greater than those of Rholp or other p2iras.related 
proteins (Bourne et al., 1990). The GTP hydrolysis rates of several p21 
proteins, Including mammalian rho, are known to be stimulated by specific 
extrinsic GAP proteins. Thus, Rholp is expected to interact with a GAP 
protein that specifically increases its GTPase activity. Likely candidates for the 
Rholp GAP are the products of the yeast genes BEM2 or BEM3 (Bem2p and 
BemSp, respectively) because each gene is known to be involved in the bud 
emergence process (Bender and Pringle, 1991). Furthermore, both Bem2p 
and Bem3p share regions of amino acid homology with the human bar gene 
product, known to accelerate the GTP hydrolysis activity of a rho-related 
protein (Diekmann et al., 1991). Bem2p was available as a fusion protein 
attached to glutathione S transferase (R. Cerione, Cornell University), and thus 
was tested for the ability to accelerate the GTPase activity of Rholp. 
Bem2p increased the initial GTPase specific activity of Rholp at a 0.2 ft M 
magnesium concentration from 0.02 to 0.03 pmol P| released/pmol 
Rholp/min. The hydrolysis activity then decreased to an activity comparable 
to that seen without addition of Bem2p, 0.02 pmol Pj released/pmol 
Rholp/min (Fig. 6). 
This finding provides a biochemical link between Rholp and Bem2p, 
which have previously been shown by genetic methods to cause similar 
phenotypes when activated or inactivated, respectively (Johnson et al., 1992; 
Bender and Pringle, 1991). The finding that Bem2p can serve as a GAP 
protein for Rholp correlates with these genetic results. The loss of function of 
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BEM2 would remove the GAP activity specific for Rholp and therefore lead to 
a higher proportion of Rhol p in an active conformation. 
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TABLE 
Table /. Purification table. 
GTP binding 
Fraction 
Total Total 
Volume Protein 
Total Specific 
Activity Activity Yield Purification 
(ml) (mg) (pmol) (pmol/^g) (%) (-fold) 
Extract 10.5 
Chromato-
focusing 
Bio Gel 
P-60 
334.0 120303 0.36 100.0 1.0 
25.8 56990 2.21 47.0 6.1 
0.46 0.015 134 8.90 0.11 24.7 
129 
FIGURES 
130 
0.35 
0.30-
0.25-
0.20-
§0.15^ 
•^0.10^ 
0.05 
40 
Fraction number 
r500 
400 
1-300 
200 
-100 
- 0  
1 
o> 
c 
1 la 
Q_ 
o 
0 
Figure 1. Chromatofocusing profile. A soluble extract from a yeast strain 
overproducing Rho1p was fractionated on a PBE 94 column eluted with a 
descending pH gradient from 6.2 to 4.0. Protein was detected by measuring 
absorbance at 280 nm. GTP binding activity was determined by the filter 
binding assay (Materials and Methods). 
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Figure 2. Detection of Rholp in chromatofocusing fractions. Samples from 
selected fractions of the chromatofocusing column shown in Figure 1 were 
analyzed by SDS-PAGE and Coomassie blue staining (Panel A). Duplicate 
gels were tested for the presence of Rholp by Western blot analysis (Panel B). 
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Figure 3. Bio-Gel P-60 profile. The Rholp containing fractions from the 
chromatofocusing column were combined, concentrated, and applied to a 
Bio-Gel P-60 gel filtration column. Protein was detected by monitoring 
absorbance at 280 nm. GTP binding activity was determined by the filter 
binding assay (Materials and Methods). 
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Figure 4. Binding affinity of Rholp for GTP. Rho1p was incubated with [a-
32p]GTP in HB buffer witli various concentrations of free magnesium. 
Samples were removed at various time intervals, and bound GTP was 
quantitated after collecting proteins by filtration through nitrocellulose. The 
number of moles of Rholp present in each assay was estimated from plots 
using raw counts of bound GTP. The data plotted as shown presents GTP 
binding as a fraction of maximal binding. Each curve is based on data from 
five separate assays and was fit to binding cun/es using the program 
ENZFITTER. 
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Figure 5. GTPase activity of Rholp. Rholp was incubated at 370C witli [a-
32p]GTP in HB buffer with varous concentrations of free magnesium. Aiiquots 
were removed at various time intervais and free phosphate was measured by 
the charcoal precipitation method (Materials and Methods). The molar 
concentration of Rholp in the assay was determined from the number of GTP 
molecules bound to Rholp at saturation, assuming one binding site per 
protein molecule (see Figure 4). 
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Figure 6. Effects of Bem2p on Rholp GTPase activity. The GTPase activity 
assay shown in Figure 5 was repeated in the presence of glutathione S 
transferase-Bem2p fusion protein (GST-Bem2p), or in a control experiment 
with glutathione S transferase alone (GST) at a free magnesium concentration 
of0.2/xM. 
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GENERAL SUMMARY AND CONCLUSIONS 
The work described in this dissertation was done to gain insight into the 
physiologicai function of Rho1p. To do this, yeast strains expressing altered 
levels of Rho1p activity were morphologically characterized, Rho1p was 
localized in the yeast cell, and Rholp was purified and biochemically 
characterized. 
Yeast strains were constructed to cause either high or low levels of Rholp 
activity by modification of the normal RH01 gene. These strains were 
characterized by flow cytometry for DNA content and by immunofluorescence 
microscopy. Strains that contained elevated levels of Rholp activity either 
overexpressed RH01 or expressed the activating point mutant A 
strain that expressed low levels of Rholp activity had its single copy of RH01 
under repression from a conditional promoter. The morphology of these 
strains was studied by fluorescence staining for actin, tubulin, DNA, chitin, and 
Rholp. Elevated levels of Rholp caused greatly enlarged, unbudded, 
polyploid cells, whereas low levels caused a phenotype indicative of excessive 
budding. The cells expressing high Rholp activity also displayed excessive 
chitin deposition and an abnormal actin cytoskeleton. Rholp, therefore, 
functions as a negative regulator of morphological development in the yeast 
cell cycle, most likely acting through the secretion process and involved in the 
regulation of the assembly/disassembly of the actin cytoskeleton. 
The location of Rholp In the yeast cell was determined by two methods, 
immunofluorescence microscopy and subcellular fractionation. Polyclonal 
antibodies were used to localize Rholp in the yeast cell and to identify Rholp 
in fractionation studies. These antibodies were made against two fusion 
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proteins expressed In £ coli. These included a lacZ fusion using the pUR 
vector system, and a trpE fusion using the pATH vector system. The trpE-
RH01 antibodies were affinity purified using the lacZ-RH01 fusion protein 
bound to CNBr-activated Sepharose. Immunofluorescence microscopy 
showed a punctate staining pattern around the periphery of the cell. 
Subcellular fractionation studies utilized immunoblots to localize the protein to 
a membrane fraction. In studies done using sucrose density gradients of the 
membrane fractions, Rholp colocalized with the Golgi apparatus markers 
kex2 and Ca2+-dependent GDPase. In fractionation studies using secretory 
mutants that accumulate secretory vesicles, there was a coincident 
accumulation of Rholp. Thus, Rholp is located in the Golgi apparatus and 
secretory vesicles which are present at the cell's periphery. This correlates 
with the genetic studies, since the actin cytoskeleton is believed to direct the 
flow of secretory vesicles to the bud. 
The final stage of research Involved the purification and characterization of 
Rholp to further delineate its function. Rholp was purified from a yeast strain 
overexpressing RH01 using the techniques of chromatofocusing and gel 
filtration. The protein was obtained with a 0.11% yield and a 25-fold 
purification. The guanine nucleotide binding and hydrolysis properties of 
Rholp were determined. Rholp bound GTP with rates of 0.08, 0.10, and 
0.034 pmol GTP bound/pmol Rholp/min at free magnesium concentrations 
of 0.2/iM, 50/tM, and 10 mM, respectively. The protein had intrinsic GTPase 
specific activity of 0.021, 0.032, and 0.028 pmol P\ released/pmol Rholp/min, 
respectively, at these same free magnesium concentrations. This GTPase 
activity was increased by incubation with the BEM2 gene product, Bem2p, 
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another gene known to be involved In the process of bud formation (Bender 
and Pringle, 1991). Thus, Rholp behaves similarly to other p2iras-reiated 
proteins In its GTP binding and hydrolysis properties and also by Its interaction 
with a GAP protein; 
The finding that Bem2p is a GAP for Rholp provides a biochemical link 
between RH01 and BEM2, which have previously been shown to cause 
similar phenotypes when they are either overexpressed {RH01 (Johnson et 
el., 1992)) or nonfunctioning {BEM2 (Bender and Pringle, 1991)), This 
correlates with the phenotypic results, since the loss of function of BEM2 
would remove the GAP activity specific for Rholp and therefore lead to a 
higher proportion of Rholp in an active conformation. 
A possible interaction between the RH01 and CDC42 genes has also 
been identified. The lack of function mutant of CDC42 has the same 
phenotype as overexpression of RH01 (Adams et al., 1990). This phenotypic 
similarity implies that these proteins may function in the same pathway but with 
opposite effects. The effector region of the two proteins, predicted to interact 
with a downstream protein in a signaling pathway, is identical over nine out of 
nine residues with the exception of one conserved substitution. Therefore, 
Rholp and Cdc42p may interact with the same effector molecule, one with an 
inhibitory and the other with a stimulatory effect. 
Growth throughout the yeast cell cycle is finely controlled. While a bud is 
present, growth is directed towards the tip of the bud. During G1 phase, when 
a bud is not present, growth is directed around the entire periphery of the cell. 
Many proteins which control the polarity of cell growth have been identified, as 
was mentioned in the introduction to this thesis. The interactions between 
139 
most of these proteins, however, have not been determined. In this study, 
possible relationships between Rholp and two other proteins involved in the 
control of polarity of cell growth, Cdc42p and Bem2p, may have been 
identified. Rholp and Cdc42p may control the polarization of cell growth by 
interacting with the same effector molecule. This effector molecule would act 
positively in a pathway causing growth to be directed to the bud. Rholp 
would have a negative effect on this polarized growth effector molecule, which 
would result in peripheral growth, while Cdc42p would have a positive effect, 
causing growth to be localized to the bud. Bem2p would also have a role in 
this pathway. Bem2p would indirectly have a positive effect on the polarized 
growth effector molecule, since Bem2p inactivates Rholp. 
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